rfhg_239184.1

Basic information about the TSS

---

TSS ID: rfhg_239184.1 TSS ID(Version3): hg_200502.1 hg_200501.1 hg_200500.1 Species: human Chr: chrX		Start: 132217272 End: 132217396 Strand: -
Source datasets	FANTOM5|PRJNA4843412|DRA013844|PRJNA615891|PRJNA401781
Protocol	CAGE|NETCAGE|SLIC_CAGE
TSS cluster detected*	5

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4312176,EH38E2768960)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL049685:0 BC003403:0 AK124801:0 GeneID: 57826 HGNC/MGI_ID: HGNC:21165 UniProt_ID: Nearer transcript ids and distances: KJ899376:3 EU832115:3 EU832161:3 EU832209:3 EU832255:3 BX647223:-66 AL832461:-206 view more...

Gene_name: RAP2C, member of RAS oncogene family Gene_symbol: RAP2C Gene_synonyms: DKFZp313B211 Gene_source: HGNC:21165

TATA-Box annotation

---

Distance to TSS:	699
Nearest PromoterID:	NM_021183
Entrez ID:	57826
Nearest Unigene:	Hs.119889
Nearest Refseq:	NM_021183
Nearest Ensembl:	ENSG00000123728
Gene Name:	RAP2C, member of RAS oncogene family
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.056452
GC%:	0.624000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAP2C p2@RAP2C p3@RAP2C p4@RAP2C p5@RAP2C p6@RAP2C p7@RAP2C p8@RAP2C p10@RAP2C
Sample		p1@RAP2C	p2@RAP2C	p3@RAP2C	p4@RAP2C	p5@RAP2C	p6@RAP2C	p7@RAP2C	p8@RAP2C	p10@RAP2C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.65	11.88	0.39	0.58	0.58	1.17	0.39	1.75	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2.83	17.80	0.81	1.01	1.62	1.82	0.20	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.59	10.22	0.96	1.35	0.77	1.16	0.39	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	3.74	10.40	0.21	0.62	1.46	1.87	0.00	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	3.60	10.57	0.22	0.90	0.67	1.80	0.45	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.29	13.18	1.16	0.58	1.55	1.94	0.00	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.66	13.51	0.87	0.65	0.65	0.87	1.09	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.60	10.90	1.70	1.45	0.97	1.70	0.48	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.42	11.75	1.71	0.21	1.71	1.71	0.43	0.64	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	7.54	1.74	0.00	1.74	0.58	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.45	6.47	1.21	1.21	0.81	1.62	0.40	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	7.32	10.57	2.85	0.41	0.81	2.03	0.41	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1.61	3.87	0.16	0.97	0.32	0.97	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1.65	4.21	0.15	0.90	0.30	0.60	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	0.66	1.98	0.22	0.66	0.22	0.66	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1.51	3.77	0.00	0.50	0.25	1.01	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1.97	2.40	0.44	0.22	0.22	0.87	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	0.84	4.22	0.00	0.42	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.13	2.67	1.07	1.07	0.00	0.53	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1.05	4.51	0.90	0.75	0.60	1.35	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1.87	3.61	0.94	0.40	0.53	1.20	0.13	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2.24	4.66	1.73	1.04	0.86	1.55	0.69	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1.29	4.01	1.03	1.03	0.26	1.42	0.39	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1.70	3.15	0.24	0.97	0.00	0.49	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	2.58	5.16	3.35	1.55	0.26	1.03	1.03	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1.27	8.86	0.95	1.58	0.63	1.27	0.32	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.85	5.49	1.65	0.55	0.00	1.65	0.00	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.13	5.19	5.89	3.30	0.94	1.18	0.24	1.65	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.23	6.30	4.85	1.13	0.48	1.29	0.65	1.29	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2.71	5.07	3.98	1.09	0.72	0.90	0.72	1.09	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.14	6.28	4.61	1.88	1.05	1.47	1.05	1.47	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.13	4.10	4.49	1.56	0.39	0.78	0.39	0.39	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	2.95	9.29	7.60	1.06	0.63	1.06	0.84	0.42	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	7.59	7.26	8.74	1.81	0.66	1.81	1.32	0.99	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	3.55	5.80	4.49	2.62	0.75	0.37	0.75	0.75	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	3.83	4.02	3.45	1.34	0.19	0.57	1.15	1.15	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	2.66	4.29	5.72	2.66	0.41	2.25	0.20	0.61	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	3.43	6.65	4.43	1.21	0.40	0.81	1.01	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2.43	6.75	4.86	2.16	1.08	0.54	0.27	1.08	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	3.36	3.84	2.64	0.96	0.24	1.20	0.96	0.96	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.06	4.23	6.82	1.65	0.24	0.94	0.94	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.54	4.39	6.73	1.90	0.44	0.88	0.88	0.73	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	2.32	4.43	4.85	2.11	0.42	1.27	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1.22	6.82	5.59	1.92	0.35	1.22	0.87	0.52	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	2.01	5.02	5.22	1.81	0.80	0.20	0.40	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1.40	6.28	3.95	0.70	0.93	1.40	0.23	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.88	4.80	2.64	1.20	0.72	0.96	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2.09	5.96	6.86	1.49	0.30	0.30	0.60	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	2.39	3.83	2.87	0.96	0.96	1.68	0.96	0.48	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	0.61	5.86	3.24	0.81	0.61	0.61	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1.84	4.92	2.87	0.82	0.82	1.02	0.20	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1.11	5.78	2.89	0.89	0.89	0.89	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	0.00	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2.13	5.32	1.42	1.06	0.35	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.65	3.65	2.65	0.99	0.00	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	2.52	6.71	9.23	0.00	1.68	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.43	5.51	6.43	0.00	0.92	0.92	0.00	0.00	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	2.59	2.92	1.62	0.65	0.00	0.97	0.65	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1.61	0.96	2.25	1.28	0.00	1.28	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.03	3.46	4.09	0.94	0.63	1.89	1.26	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	4.23	0.71	0.00	0.71	2.12	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.24	2.80	2.80	0.00	0.00	0.00	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	10.35	11.94	6.37	6.37	0.80	1.59	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.76	7.47	3.74	1.02	0.68	0.34	1.36	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	2.92	4.22	1.62	0.65	0.00	0.97	0.32	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	2.13	7.45	0.35	0.35	0.00	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	0.00	0.00	23.69	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.88	4.88	0.49	1.46	1.46	0.49	2.44	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	2.98	5.45	0.00	1.98	0.99	0.99	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.22	5.16	1.88	0.47	0.94	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.31	4.31	1.32	1.66	0.66	1.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	0.93	1.86	1.86	1.55	0.00	0.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.36	5.50	1.83	1.22	0.31	0.61	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	2.38	1.43	2.38	0.95	1.58	0.48	0.00	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	2.57	2.89	2.57	0.80	1.12	0.16	0.64	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	3.05	1.15	3.56	0.89	0.76	0.51	0.51	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	2.99	0.75	0.75	1.49	0.00	0.00	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	2.01	2.68	2.34	0.33	0.33	0.67	1.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	3.19	0.00	2.55	0.00	0.00	0.00	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	2.20	0.00	1.10	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	1.35	0.45	0.45	0.45	0.45	0.45	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	1.91	1.56	0.87	0.17	0.35	0.35	0.52	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	5.67	5.48	3.13	1.17	1.37	0.20	0.98	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	2.57	5.66	1.54	0.77	0.51	0.77	0.77	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	5.02	2.23	2.51	1.12	1.67	0.56	0.28	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	4.70	4.11	2.35	1.76	1.18	1.18	1.18	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	3.86	4.91	3.86	1.29	1.45	0.72	0.40	0.56	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	3.87	4.84	2.26	0.32	0.97	0.97	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	4.27	3.20	2.67	1.07	1.07	1.07	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	3.34	3.34	3.34	1.67	1.11	1.11	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	1.25	3.33	1.25	0.83	0.83	0.83	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	5.02	1.26	1.00	0.75	0.50	1.26	0.00	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	3.60	2.62	2.62	2.29	0.33	0.00	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	2.44	2.13	2.74	0.91	1.22	0.91	0.61	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.20	3.31	0.44	0.88	0.22	0.88	0.00	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.00	1.08	0.36	0.00	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	2.34	5.76	1.26	1.80	0.36	0.36	0.36	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	3.35	0.00	1.67	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.26	2.26	1.23	2.26	0.00	0.00	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	7.90	3.66	0.34	2.06	0.00	1.14	1.03	0.46	0.11
Anulus Pulposus Cell, donor2	11463-119B5	5.63	1.96	0.24	0.98	0.00	0.00	1.47	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.94	1.80	0.45	0.90	0.45	1.35	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.21	1.74	0.87	2.60	0.00	0.87	1.74	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	3.59	0.00	0.90	2.09	0.30	0.00	1.20	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	1.26	0.00	2.53	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.98	0.66	0.00	0.66	0.00	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.52	2.27	0.00	0.97	0.65	0.65	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	3.88	0.00	2.91	1.46	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	1.19	0.00	1.78	0.00	0.59	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	2.26	0.75	1.13	0.00	0.75	0.75	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	0.73	0.00	0.00	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	0.00	1.25	1.25	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	2.47	0.66	2.47	0.16	0.66	1.15	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	0.00	0.00	0.00	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.07	0.90	0.60	2.11	0.45	0.30	0.75	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	1.07	1.07	3.21	0.00	0.00	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.16	3.02	0.38	0.94	0.76	0.57	0.76	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.54	1.60	0.80	1.34	0.27	0.80	0.53	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	3.90	0.98	0.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	3.65	2.16	0.66	1.66	0.00	0.33	0.66	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	3.60	0.00	1.20	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	7.08	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.77	1.72	1.37	1.37	0.51	0.17	0.34	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	2.43	0.49	1.46	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	3.42	3.79	0.00	1.52	0.38	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	1.21	0.00	2.42	0.00	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	1.71	0.00	1.14	0.00	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.28	2.99	0.64	1.71	0.43	0.00	0.64	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	2.84	1.29	0.26	0.77	0.52	0.52	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	3.75	0.94	0.47	0.47	0.47	0.47	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.22	1.93	0.00	1.29	0.96	0.00	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	0.71	0.71	0.00	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.09	1.75	0.00	1.17	0.00	0.00	0.58	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.82	2.41	0.00	0.90	0.60	0.30	0.00	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	4.75	1.19	1.19	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	2.54	0.51	1.53	0.51	0.00	1.02	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.84	2.29	0.76	1.27	0.51	1.53	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	0.64	0.00	0.64	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.02	2.59	0.00	2.59	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.02	2.75	1.48	0.64	0.21	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1.74	1.74	0.58	0.58	0.87	0.87	0.29	1.45	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	1.89	0.00	3.78	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.22	1.53	0.34	0.85	0.17	0.68	0.85	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	0.00	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.29	1.72	0.64	0.86	0.21	0.43	1.07	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	1.20	0.60	0.60	0.00	1.20	1.20	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	2.19	0.73	1.46	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.82	2.53	1.38	2.76	0.46	0.92	0.00	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	1.78	0.76	2.80	0.51	0.00	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.16	4.13	1.03	1.86	0.41	1.24	0.41	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.14	2.14	0.31	1.53	0.31	0.00	0.61	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.17	2.39	1.43	3.82	0.00	0.00	0.96	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4.88	1.77	0.00	1.33	0.00	0.22	0.67	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	0.00	0.00	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	3.32	1.11	1.11	2.77	0.00	0.55	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.56	2.38	0.53	2.91	1.06	0.79	0.53	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	0.73	0.73	0.00	0.00	0.73	0.73	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	1.97	2.82	0.86	0.49	0.12	0.98	0.74	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	1.54	1.71	0.17	0.17	0.51	1.03	0.00	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	0.42	4.40	0.42	0.42	0.00	1.68	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	2.79	7.67	1.05	0.70	0.35	1.39	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	1.94	10.84	0.97	0.49	0.49	1.78	0.32	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	3.13	8.50	1.34	0.15	0.45	2.54	0.75	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	8.37	7.80	3.21	10.78	2.18	0.69	0.69	0.46	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	6.89	7.14	3.63	9.52	1.00	0.63	0.50	0.75	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	9.33	5.92	3.19	8.88	1.37	1.37	0.68	0.34	0.11
Basophils, donor1	12241-129G9	38.45	18.05	7.32	5.75	10.46	0.78	1.83	0.78	0.52
Basophils, donor2	12242-129H1	64.58	21.29	14.43	18.40	11.91	0.36	0.72	1.08	0.36
Basophils, donor3	12243-129H2	18.96	15.58	6.61	3.82	6.17	0.73	0.88	1.91	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	2.37	2.16	0.43	0.86	1.08	0.00	0.00	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	0.63	0.63	0.63	0.63	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.04	1.66	0.21	0.83	0.62	0.62	0.00	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.38	1.61	1.15	0.92	0.00	0.23	0.92	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3.24	1.26	1.44	2.16	0.18	0.36	0.72	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.49	7.83	1.55	4.53	0.72	1.65	0.10	0.52	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	2.33	6.06	3.26	1.16	0.70	1.16	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	6.40	2.88	3.84	2.56	0.32	0.96	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	44.52	27.05	15.78	3.38	6.20	0.00	1.13	4.51	5.07
CD14+ Monocytes, donor2	11305-117B9	33.59	30.62	11.88	4.83	5.20	1.30	1.86	2.23	1.67
CD14+ Monocytes, donor3	11381-118B4	31.83	22.83	10.54	2.41	3.73	0.88	1.32	1.54	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.04	6.51	8.21	3.40	3.11	2.26	1.13	0.85	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.92	3.79	11.37	5.69	1.90	0.76	1.52	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	13.81	3.62	10.19	3.62	3.29	1.64	2.30	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	23.13	3.76	3.18	2.02	5.78	0.72	2.75	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	19.01	2.72	2.41	2.72	3.92	1.81	0.60	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	22.50	6.87	2.61	4.74	6.87	1.18	2.37	1.66	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	8.04	4.35	2.68	8.20	1.17	3.01	1.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.70	6.62	5.52	3.04	5.24	0.83	0.83	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.21	6.45	4.46	5.70	7.93	0.99	2.73	0.99	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	16.64	6.66	1.76	1.96	6.07	0.59	1.57	1.37	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.31	3.74	3.20	4.10	5.16	0.36	0.89	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.26	4.57	8.27	5.66	6.75	1.31	2.18	1.52	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.90	9.13	5.62	3.51	13.58	0.70	2.58	1.64	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.79	8.45	7.39	4.75	5.28	1.06	0.00	1.58	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	52.14	4.44	2.22	5.55	5.55	2.22	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	26.18	5.95	3.12	2.97	8.92	1.34	3.72	1.49	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.34	4.39	1.00	4.79	3.99	0.40	1.40	1.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	45.39	5.41	3.75	8.54	7.08	0.42	2.50	3.33	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	37.06	8.69	8.01	4.58	15.33	0.69	4.58	3.43	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	43.20	8.37	5.20	5.88	9.05	0.45	2.26	2.26	1.58
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	37.10	9.60	8.29	9.17	13.97	0.44	1.75	3.06	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.48	4.30	2.69	2.96	5.92	0.81	1.34	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.83	5.93	3.84	2.44	4.71	0.00	0.87	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	22.72	4.63	3.37	4.21	8.00	1.26	0.84	1.68	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	70.36	12.12	20.39	4.41	21.49	0.92	4.78	4.41	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	56.01	16.20	17.97	5.64	14.44	2.11	1.76	2.47	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	78.09	17.99	23.69	16.67	18.43	1.75	4.39	3.95	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.68	3.49	2.96	0.70	7.15	0.17	1.57	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.01	5.20	1.49	1.86	5.20	0.00	1.86	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	25.22	6.04	4.31	5.39	6.25	0.43	1.29	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	52.41	14.33	18.02	7.78	14.74	0.41	2.46	4.91	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	65.83	17.85	21.56	10.66	13.91	1.39	3.48	3.01	4.64
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	127.36	24.36	33.87	20.65	16.47	2.32	6.50	7.89	4.64
CD14+CD16+ Monocytes, donor1	11789-124B7	21.14	4.80	10.46	2.83	4.80	0.22	1.74	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	32.34	8.32	14.09	3.46	7.85	0.69	2.08	1.85	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	19.50	5.85	8.45	1.52	3.03	0.00	1.95	0.87	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	17.29	5.61	5.61	2.80	4.98	0.31	2.80	2.18	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	16.42	3.84	6.11	1.22	5.41	0.87	2.10	1.05	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	23.63	7.80	9.14	1.11	5.80	0.89	2.45	1.56	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	27.81	2.04	10.72	4.85	4.85	0.77	1.79	1.53	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	41.28	5.27	14.71	3.51	5.05	0.22	1.54	1.54	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	36.21	3.16	14.32	4.42	4.00	0.21	2.74	1.47	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	10.16	6.10	6.10	6.10	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.88	4.75	4.07	2.71	6.78	1.36	0.68	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	19.68	3.11	12.43	11.39	6.21	1.04	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	17.06	11.73	10.13	11.73	5.86	2.67	0.00	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	21.44	8.04	9.11	11.26	11.79	2.14	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.85	8.42	11.93	9.13	4.21	1.40	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	16.47	10.20	7.06	6.27	3.92	0.00	1.57	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	2.64	5.27	14.50	3.95	6.59	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	36.16	21.37	8.22	7.40	6.58	1.64	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	38.45	25.39	10.88	7.98	4.35	1.45	1.45	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	33.32	32.31	12.62	9.59	4.04	2.52	0.50	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.62	0.40	12.93	0.81	0.00	0.40	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.80	0.80	6.79	0.80	1.20	0.00	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	5.02	2.01	5.02	1.00	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	58.43	25.84	14.61	12.36	3.93	1.69	0.00	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.52	7.14	0.75	2.63	1.50	0.00	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.47	3.38	0.23	2.93	1.58	1.35	1.58	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	69.27	8.21	3.21	22.49	3.21	2.14	0.71	2.50	0.00
CD4+ T Cells, donor2	11306-117C1	53.28	1.84	1.84	11.63	1.84	0.00	0.61	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	48.49	5.18	1.83	12.50	1.52	0.00	0.30	3.96	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	11.49	0.26	2.04	5.87	3.06	0.26	1.02	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	11.90	0.90	0.90	4.49	2.25	0.45	0.00	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	10.64	2.87	1.15	6.61	1.72	0.00	0.29	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	46.46	3.32	3.32	9.48	2.84	0.00	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.16	3.51	1.40	9.13	1.40	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.50	1.45	2.46	7.66	3.90	0.14	0.00	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.73	1.69	1.02	4.91	1.86	0.17	1.53	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	13.70	1.29	0.97	4.35	1.77	0.64	0.32	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	38.55	2.69	2.69	13.45	0.90	0.00	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.75	2.80	1.75	13.63	3.14	0.35	0.35	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.52	4.84	3.08	15.84	3.52	1.32	0.44	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.77	2.95	1.26	10.54	2.53	0.00	0.00	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	9.14	1.66	0.83	7.27	2.29	0.21	0.62	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.68	1.34	1.67	5.68	0.67	1.00	0.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	59.55	1.09	3.54	17.95	2.99	0.82	1.09	1.09	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	57.88	2.68	1.61	17.15	2.68	0.54	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	1.79	1.79	8.97	3.59	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.43	2.60	2.97	5.56	4.08	0.37	1.11	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	14.08	1.52	1.52	6.72	3.47	0.00	0.43	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.03	2.73	2.73	7.36	4.62	0.42	0.42	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	36.91	3.54	4.04	14.16	1.52	0.51	0.00	2.02	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	30.76	3.03	0.87	16.46	5.20	0.87	1.30	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	57.09	3.92	2.18	25.28	1.31	0.44	0.00	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	20.78	2.47	5.94	17.32	7.42	0.49	1.48	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	16.62	1.85	6.46	16.62	2.77	0.00	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	4.19	2.79	19.54	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	24.65	3.32	7.48	16.62	4.98	0.55	0.55	1.11	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	30.67	5.40	9.57	22.82	3.19	0.98	0.49	0.49	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	1.54	7.70	20.02	6.16	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.41	1.43	7.52	15.04	5.73	0.00	0.36	0.72	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	18.00	4.15	6.92	27.70	1.38	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	47.14	11.46	11.46	24.55	3.60	1.31	0.33	0.65	0.65
CD8+ T Cells, donor2	11307-117C2	32.29	10.51	5.26	19.15	4.13	0.38	0.38	1.50	0.75
CD8+ T Cells, donor3	11383-118B6	40.65	15.15	6.06	18.94	4.29	0.76	0.25	0.76	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.13	1.84	1.84	2.06	0.69	0.69	0.46	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.59	2.64	2.88	1.20	0.24	0.72	0.48	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	2.46	0.55	0.82	0.55	0.55	0.55	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.41	1.80	3.60	3.00	1.20	1.50	1.20	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.36	3.12	2.64	1.20	0.48	0.00	0.72	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.32	4.09	2.27	0.45	0.45	0.68	1.36	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.26	1.96	1.30	2.39	0.65	0.22	0.22	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.16	1.84	2.11	2.11	0.53	0.53	0.53	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.69	1.41	2.35	1.41	0.70	0.47	0.94	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.32	2.42	2.42	1.81	1.21	0.30	0.30	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.68	2.91	4.65	4.07	0.29	0.87	0.29	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.46	2.13	2.93	1.60	0.27	1.07	1.07	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4.82	3.06	2.63	1.31	0.44	0.88	0.44	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.65	3.64	2.73	1.37	0.00	0.91	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	2.98	1.49	1.49	1.49	0.00	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.76	5.40	1.80	1.08	0.36	0.72	0.36	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.32	4.32	1.44	1.73	0.58	0.29	1.44	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.83	2.59	1.18	2.59	0.47	0.47	1.18	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	2.85	4.44	3.80	1.27	0.63	0.63	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	9.23	2.15	2.77	2.46	0.31	0.31	0.62	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	4.49	0.96	2.89	0.32	0.96	0.64	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	4.21	1.53	1.91	0.00	1.15	1.53	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.85	2.36	1.58	1.18	0.00	1.18	1.58	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	2.27	0.00	2.27	0.00	0.00	0.00	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	3.21	9.64	4.01	0.00	1.61	2.41	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	4.90	9.09	5.60	0.00	1.40	2.10	2.80	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	8.01	4.01	1.00	4.01	1.00	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	1.83	7.31	0.00	0.00	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	3.46	4.45	0.00	0.49	0.49	0.00	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	5.05	4.42	1.37	1.58	0.32	0.84	0.42	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	7.28	3.81	3.12	2.43	0.00	1.04	0.35	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	1.78	2.84	1.78	1.07	0.36	0.71	0.36	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.53	4.10	3.07	2.39	0.46	0.68	0.80	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	9.85	1.79	0.00	6.27	0.90	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	5.26	3.64	2.02	2.83	0.81	0.40	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	10.44	6.77	0.69	5.28	0.57	1.26	1.15	0.57	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	7.05	5.34	0.86	3.21	0.43	0.64	0.64	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	6.64	5.84	0.27	3.27	0.44	0.35	1.33	0.44	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	7.52	5.87	11.28	3.48	0.64	0.92	1.01	2.20	1.28
Corneal Epithelial Cells, donor1	11526-119I5	0.66	0.66	0.66	0.00	0.66	0.00	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	0.00	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	0.51	1.02	1.28	0.51	0.26	0.26	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.38	5.94	7.59	6.60	1.49	1.32	1.32	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.09	5.68	7.25	9.15	1.89	0.63	1.58	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	0.00	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.02	5.94	6.80	3.13	0.76	0.86	0.65	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	39.29	14.01	9.22	7.17	1.37	1.71	1.37	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	38.52	13.06	9.79	7.83	0.65	1.31	1.31	2.61	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	46.94	13.55	14.03	11.61	6.29	0.97	1.94	1.94	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	3.67	2.00	0.67	1.33	1.00	1.00	0.67	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	2.35	3.52	0.00	0.59	0.59	0.00	0.00	2.35	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.66	2.26	1.70	1.98	0.00	0.57	0.28	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	1.97	3.15	1.57	1.18	0.79	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.62	1.75	0.29	0.29	0.00	0.58	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	2.35	3.06	0.71	1.18	0.47	0.94	0.47	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	3.51	1.93	0.35	0.88	0.53	0.18	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.43	1.33	0.89	1.11	0.89	0.66	0.22	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.61	3.04	3.04	1.52	1.22	0.00	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	7.05	1.97	1.41	2.82	0.85	1.13	0.28	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	4.46	1.78	1.49	1.19	0.59	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	1.56	0.52	1.56	1.04	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	0.99	1.70	0.85	0.43	0.14	0.57	0.57	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	7.60	3.60	1.20	3.60	0.00	1.20	1.20	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	0.00	2.10	0.52	0.00	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.66	5.84	1.86	5.72	0.62	0.87	1.24	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.95	3.26	1.30	1.96	0.65	0.22	0.65	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	5.13	2.69	1.71	1.47	0.85	0.98	0.73	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	2.28	3.41	0.00	1.14	1.14	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	0.00	1.40	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	2.83	3.93	0.47	1.26	0.79	2.20	0.79	0.16	0.00
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	60.99	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	99.02	94.06	16.50	23.10	54.46	3.30	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	135.54	60.64	14.27	17.83	67.77	0.00	14.27	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.22	2.20	0.49	0.73	0.49	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.69	2.87	0.82	2.46	1.23	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.20	0.99	0.99	0.88	0.33	0.33	0.88	0.44	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.58	3.90	1.84	0.87	0.76	1.41	1.19	0.33	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	4.85	4.49	1.82	2.06	0.61	1.09	0.97	0.61	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	3.55	1.09	4.09	1.09	0.68	0.27	0.41	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.32	3.80	1.16	1.90	0.32	0.74	0.63	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3.43	2.63	4.22	1.58	0.53	0.79	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	3.99	2.66	2.33	1.66	0.66	0.66	0.66	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	1.81	3.18	0.91	0.91	0.45	1.81	1.36	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	3.79	3.03	3.79	3.03	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	1.89	1.58	0.32	1.42	0.00	0.00	0.16	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	4.24	6.67	2.12	1.21	0.61	1.82	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	3.30	3.43	1.40	1.78	0.76	1.27	0.51	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	2.58	4.24	1.52	1.67	0.45	0.30	0.30	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	6.83	4.02	1.74	0.67	0.00	0.40	1.21	0.94	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	2.59	0.86	4.31	0.43	0.43	1.73	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	0.00	4.39	1.46	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.92	8.53	0.92	0.69	0.69	0.69	0.69	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	9.67	6.11	2.37	2.04	0.34	0.85	1.02	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	2.35	2.11	2.35	1.17	0.23	0.94	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	1.42	0.47	0.47	0.00	0.94	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.87	2.90	2.18	2.06	0.12	0.48	0.24	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	5.31	3.62	1.36	1.13	0.45	1.13	0.90	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	4.36	2.97	1.40	0.35	0.17	1.22	0.70	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	5.04	5.20	1.95	0.65	0.81	1.14	0.49	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	5.21	3.12	2.92	2.50	0.21	1.04	0.62	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	5.76	6.55	2.88	3.14	1.83	0.79	1.57	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	5.40	4.09	1.71	2.37	0.53	1.45	1.19	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	4.93	6.38	3.87	1.55	0.48	0.97	0.48	0.58	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	3.12	5.19	4.16	1.04	4.16	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5.29	4.93	2.47	1.59	0.53	0.70	1.41	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	6.55	7.17	2.65	2.18	2.34	0.94	1.25	0.47	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	5.81	3.79	2.57	1.49	0.81	1.22	0.81	0.54	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1.76	17.64	3.88	0.35	3.53	3.18	0.71	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.31	5.41	1.32	1.61	1.02	1.17	0.73	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.04	3.95	3.55	2.59	0.41	1.36	1.64	0.27	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	4.61	6.14	2.63	1.21	0.77	0.99	1.10	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	2.93	6.60	1.47	0.44	0.44	0.88	1.91	0.29	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	1.36	1.36	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	2.98	0.00	2.98	1.49	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	2.11	3.59	0.63	1.06	0.00	0.84	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	2.50	2.50	0.83	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	1.40	1.40	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.84	0.28	0.00	0.00	0.00	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	2.84	4.87	3.25	0.41	0.81	1.22	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	5.04	4.66	0.97	1.16	0.39	1.75	0.58	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	5.76	8.49	1.82	0.76	1.52	1.82	0.76	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	4.90	4.28	3.06	1.84	0.92	1.22	0.61	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	4.20	7.25	1.14	1.14	2.29	1.14	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	4.05	1.89	1.62	0.81	1.08	0.81	0.81	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	2.20	2.67	1.86	0.58	0.81	0.81	1.16	0.70	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.08	4.09	0.77	3.87	0.44	0.66	0.66	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3.25	3.45	0.81	0.81	0.61	0.61	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	2.00	0.67	0.00	0.00	1.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.54	2.37	0.40	1.19	0.00	0.00	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2.38	2.58	3.57	0.99	0.40	0.20	0.40	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.51	3.02	1.42	1.42	0.18	0.36	0.89	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	8.87	4.14	3.55	1.77	0.79	0.39	0.39	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	4.21	1.50	4.21	1.81	0.00	0.60	0.60	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.01	3.24	2.70	2.91	0.54	0.76	0.32	0.65	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	5.82	2.28	4.56	2.28	0.00	0.51	0.76	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	7.55	2.13	1.80	2.46	0.33	0.66	0.33	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3.21	1.80	6.02	0.60	0.00	0.40	0.40	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	8.44	4.62	3.62	4.42	0.40	1.41	1.00	1.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2.12	3.93	3.63	0.91	0.30	0.00	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	7.37	3.23	2.07	2.90	0.50	0.75	0.83	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.51	4.44	1.54	4.44	0.00	0.17	0.68	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.63	2.63	4.60	0.99	0.33	0.33	0.99	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.03	3.30	4.05	2.13	0.85	1.07	0.75	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	3.88	6.41	1.35	1.01	0.34	0.67	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.55	3.14	1.57	2.51	0.47	1.10	0.94	0.94	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	0.00	2.61	0.00	0.87	0.00	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.03	3.64	0.69	1.39	1.56	0.52	0.35	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.20	2.86	2.34	2.60	1.56	1.04	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	2.81	4.09	1.53	1.53	1.28	0.77	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.12	8.42	3.06	3.06	0.00	1.53	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.10	15.95	0.00	3.19	0.00	3.83	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.56	8.84	0.86	2.28	0.57	1.71	1.71	2.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.96	12.96	1.65	2.21	0.55	6.34	1.93	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	5.71	13.93	2.74	1.83	0.68	1.37	1.37	1.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	7.53	8.12	1.39	2.18	0.99	1.59	0.79	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.61	11.10	0.79	2.38	0.53	3.17	0.79	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.61	11.09	3.26	2.61	0.98	1.30	0.98	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	6.19	9.73	1.77	3.10	0.00	2.65	1.77	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	15.12	24.31	2.26	2.83	1.13	4.24	1.84	1.84	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	13.42	25.00	2.46	4.43	0.99	7.14	1.60	2.22	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.16	20.42	1.07	2.95	0.00	3.76	3.49	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.09	19.08	2.11	3.22	1.12	4.46	2.35	1.86	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	15.09	20.76	1.80	1.94	0.42	4.29	1.52	0.97	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.37	15.25	2.03	4.27	0.61	2.24	2.24	1.42	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	12.09	16.89	1.14	1.83	0.46	1.83	1.83	2.05	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.71	19.31	1.62	3.24	0.75	3.74	2.74	1.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	10.93	19.45	1.31	3.06	0.87	3.06	1.97	1.97	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.39	17.73	0.89	2.95	0.00	1.77	3.55	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.60	21.62	1.75	1.91	1.27	2.86	1.43	1.75	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.95	21.90	2.23	2.68	0.22	3.13	2.23	2.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	15.12	23.39	2.22	2.62	0.20	1.81	1.61	2.02	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.12	18.66	2.04	2.54	0.68	2.88	1.36	1.87	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.39	25.89	4.70	4.52	1.77	3.72	2.39	2.04	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.05	33.51	2.91	2.71	0.31	3.54	3.75	2.29	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.15	28.69	2.73	1.88	0.17	2.05	1.71	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.94	22.57	1.88	1.99	0.44	3.43	2.21	1.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.63	20.88	2.58	3.41	1.83	2.41	2.16	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.95	21.03	3.06	4.49	1.02	1.84	0.61	1.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.41	17.54	2.68	3.30	1.03	1.86	2.68	1.44	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	19.02	25.60	2.54	3.46	1.73	3.92	2.88	1.27	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	13.34	20.35	2.33	3.00	1.17	2.00	3.00	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	15.65	21.16	2.42	3.97	0.22	1.54	3.97	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.08	19.43	1.97	5.17	0.61	2.83	1.60	0.86	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.78	18.15	2.27	2.11	0.65	2.59	2.27	1.30	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	22.77	2.89	3.85	0.96	0.96	3.21	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.95	16.87	1.04	2.37	1.33	2.94	2.46	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.39	15.18	2.37	1.11	1.27	1.11	1.74	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	17.33	2.13	1.82	0.61	0.61	2.13	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	13.38	14.53	1.78	2.40	1.25	3.45	1.78	0.73	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.88	14.93	4.61	2.20	0.22	1.54	2.42	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.01	13.47	1.12	2.81	1.12	1.40	2.24	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	9.44	17.04	1.76	1.39	1.76	1.57	0.83	0.83	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	4.81	12.57	2.41	2.67	0.27	1.87	2.41	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.93	14.23	2.60	1.68	0.77	1.68	1.68	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.75	14.38	1.30	1.55	1.17	2.20	1.30	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.95	14.64	1.90	2.44	0.81	1.36	1.63	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.41	17.88	5.53	3.87	1.11	1.11	4.06	1.11	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.20	16.01	3.07	2.63	0.44	2.63	2.19	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	19.83	5.95	1.98	0.00	3.97	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.77	18.73	3.96	4.09	0.66	1.58	2.37	1.58	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.36	18.76	2.42	3.03	1.82	1.21	3.23	2.42	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.35	46.77	7.88	6.61	1.52	8.39	2.03	1.52	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.74	16.72	1.99	5.97	1.19	5.37	1.79	1.39	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.47	20.34	1.69	2.93	0.62	4.62	1.85	1.08	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	9.62	29.66	0.61	2.66	0.82	4.50	1.23	1.84	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.70	13.77	3.44	3.44	0.00	3.44	1.56	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.89	10.45	0.85	1.70	0.00	3.11	1.41	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.15	15.22	0.92	3.23	1.38	3.23	2.77	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	29.70	0.00	2.47	0.00	4.95	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.93	19.34	3.09	3.48	0.39	3.09	3.48	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	25.67	1.60	8.02	1.60	1.60	6.42	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	15.65	0.00	5.22	3.48	3.48	5.22	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	21.16	17.90	2.28	2.93	0.65	1.63	3.58	4.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.59	14.41	4.12	2.47	0.41	2.47	2.88	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	16.66	0.00	3.33	0.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	19.30	15.66	3.08	3.36	1.40	3.36	2.52	2.24	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.98	20.26	2.94	2.29	0.00	3.27	2.61	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	15.10	1.68	5.03	1.68	2.52	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	21.31	19.40	5.09	2.23	0.32	4.45	3.82	2.23	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.74	14.95	4.08	3.74	0.00	2.04	3.74	2.72	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	10.44	0.00	0.00	0.00	0.00	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.19	16.04	5.15	6.30	1.72	2.86	1.72	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	13.32	3.26	1.78	0.00	2.66	2.37	2.37	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	27.11	10.16	6.78	0.00	6.78	1.69	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.30	20.30	14.08	4.56	0.00	2.49	4.14	5.38	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	17.95	17.72	2.53	4.83	0.46	3.22	3.22	2.07	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	15.81	15.81	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.22	18.84	8.07	3.84	1.15	0.77	3.84	2.69	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	19.56	20.54	7.82	5.22	0.00	1.96	2.61	2.93	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	15.38	6.69	4.68	0.00	2.01	2.01	4.68	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	27.35	25.43	13.48	3.08	0.39	2.70	4.24	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.55	38.34	18.49	8.22	0.00	4.11	5.48	6.85	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	24.85	7.45	4.97	2.48	0.00	4.97	9.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.42	20.29	7.08	4.25	1.42	3.30	3.30	2.83	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	30.78	15.69	6.03	1.21	2.41	5.43	1.21	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	24.42	15.26	8.14	0.51	3.56	3.05	3.05	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	23.13	25.13	15.55	4.79	0.80	3.59	3.59	3.19	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.56	22.20	15.79	9.87	0.99	4.93	3.45	3.95	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	23.61	14.17	4.72	0.00	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.84	19.25	15.17	5.83	0.00	2.33	0.58	3.50	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.92	25.89	14.04	7.46	0.88	2.19	5.71	4.39	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	31.36	11.87	5.93	0.00	0.85	5.09	5.09	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.33	13.73	7.16	2.39	0.60	2.39	2.39	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	17.95	12.13	2.43	0.00	2.43	2.91	3.88	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	3.42	3.42	1.14	2.28	0.00	0.00	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	0.83	2.08	0.83	0.42	0.83	1.25	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	4.50	0.00	0.00	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.12	0.95	1.27	0.95	0.32	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.27	0.84	0.42	0.42	0.42	0.00	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.94	4.06	3.48	2.90	0.58	0.70	1.51	1.39	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	7.60	6.08	3.21	4.05	0.17	0.34	1.18	0.68	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.10	5.46	3.64	4.78	0.91	0.46	0.91	1.82	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.51	5.25	4.15	3.72	0.66	0.98	1.53	1.97	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.74	4.30	3.44	4.51	0.43	0.00	1.50	0.86	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.69	4.09	4.31	2.37	0.43	0.22	0.86	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.22	3.99	3.61	3.36	1.49	1.12	0.62	0.75	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.69	3.60	2.74	4.12	0.34	0.86	0.69	1.20	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.41	5.13	0.96	3.20	0.32	1.28	1.60	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	3.92	0.00	1.68	0.00	0.00	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.30	4.76	0.87	0.43	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	0.71	2.82	0.71	0.00	0.35	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	0.73	2.18	0.73	0.73	0.00	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.37	2.80	1.22	1.05	0.17	0.35	0.17	0.70	0.00
Hepatocyte, donor1	11523-119I2	9.68	2.42	12.11	6.05	0.00	1.21	1.21	0.00	2.42
Hepatocyte, donor2	11603-120I1	8.62	6.46	10.77	3.23	1.08	1.08	0.00	2.15	0.00
Hepatocyte, donor3	11684-122I1	7.36	2.45	6.14	2.45	2.45	1.23	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	6.53	0.65	0.00	0.65	0.00	1.31	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	7.17	15.38	2.62	2.62	1.05	1.75	1.05	1.40	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.76	3.02	0.00	1.92	0.55	1.78	0.96	0.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	7.69	5.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	1.62	0.00	0.00	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	3.33	1.67	0.00	1.67	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	5.29	1.32	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2.52	6.30	0.00	0.00	0.00	1.89	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	4.52	0.65	0.00	0.65	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	8.05	0.00	0.00	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	2.44	0.00	1.63	0.81	2.44	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.52	4.20	1.68	0.42	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	2.41	8.04	0.00	0.80	0.00	2.41	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	3.69	0.00	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	4.25	0.47	0.94	0.47	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	3.63	0.00	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	2.15	0.00	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	3.81	0.00	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	6.38	0.00	0.00	0.00	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	9.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	7.85	1.43	0.00	0.71	4.28	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.85	3.40	0.00	0.31	0.00	0.00	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	5.27	3.51	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	2.09	0.00	0.00	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	0.87	0.00	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	4.50	4.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	7.47	1.07	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	1.39	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1.84	5.52	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	6.34	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	2.04	2.86	1.55	0.65	0.33	0.57	0.16	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	2.34	2.93	0.00	0.59	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	3.79	2.75	1.80	2.93	0.19	0.76	0.57	0.57	0.09
Keratinocyte - oral, donor1	11251-116E9	8.29	5.79	1.36	5.90	0.79	1.36	1.25	0.45	0.00
Keratocytes, donor1	11527-119I6	2.06	6.88	2.06	0.00	0.00	1.03	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	2.34	1.17	0.00	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	5.14	10.08	1.38	0.99	0.20	0.59	0.59	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	6.59	0.00	2.20	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	4.31	0.00	0.00	0.00	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	3.58	7.61	0.46	1.15	0.46	1.61	0.69	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	6.86	8.38	1.51	4.84	0.61	1.11	1.41	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	3.32	1.19	0.59	0.95	0.24	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1.95	0.28	1.12	0.28	0.00	0.00	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.88	1.26	0.31	0.63	0.00	0.47	0.63	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.61	0.54	0.54	1.08	0.00	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	1.26	0.95	0.00	0.32	0.00	0.32	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.29	0.43	0.32	1.08	0.11	0.32	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.05	2.46	0.41	1.64	0.00	0.41	0.82	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.01	1.01	0.25	0.25	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	1.55	0.84	0.42	0.84	0.28	0.14	0.42	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.56	1.58	0.79	1.58	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	2.33	2.13	0.39	1.55	0.19	0.78	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.37	0.56	0.19	0.00	0.00	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.57	1.05	0.35	1.39	0.00	0.35	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.62	2.15	0.72	0.72	0.24	0.48	0.48	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.79	0.69	0.14	0.69	0.00	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.54	0.92	0.31	0.62	0.31	0.31	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.56	0.62	0.31	0.31	0.00	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1.10	0.73	0.18	0.91	0.00	0.18	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	2.96	0.99	0.00	0.33	0.33	0.00	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.05	0.29	0.29	0.00	0.29	0.29	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.74	1.24	0.00	0.50	0.00	1.00	0.50	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.70	2.42	0.48	1.94	0.00	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.77	1.35	0.00	1.35	0.00	0.54	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.06	1.36	0.61	0.61	0.00	0.30	0.45	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	0.52	0.52	1.04	0.00	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.77	0.84	1.05	1.26	0.21	0.63	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1.50	1.05	0.45	0.60	0.30	0.15	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	3.44	0.69	0.69	1.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	2.26	1.13	0.19	1.32	0.19	0.19	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.06	0.53	0.11	0.85	0.21	0.11	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	2.91	0.97	0.97	2.42	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1.65	2.32	0.33	0.99	0.00	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.12	0.87	0.37	0.25	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	2.96	0.74	1.11	0.00	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.45	1.98	0.74	1.48	0.00	0.74	0.49	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.79	0.69	0.00	0.41	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2.57	2.25	0.32	1.29	0.00	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.87	1.83	0.61	1.52	0.00	0.61	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3.78	0.70	0.42	0.98	0.14	0.28	0.42	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.27	1.42	1.07	1.07	0.00	0.00	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.42	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.31	0.47	0.00	0.16	0.00	0.16	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1.43	0.72	0.36	0.72	0.36	0.00	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.63	0.65	0.33	0.98	0.00	0.65	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.00	0.47	0.47	0.24	0.00	0.47	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4.21	1.98	0.50	0.87	0.12	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	0.77	0.77	0.00	0.00	0.00	0.00	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.49	0.60	0.60	0.00	0.30	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	11.33	6.80	4.53	2.27	0.00	4.53	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	13.81	3.84	4.60	4.60	0.00	2.30	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	4.45	2.23	6.68	0.74	0.74	0.74	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.50	8.46	2.54	5.92	0.42	0.42	5.08	2.96	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	6.33	1.41	5.63	0.00	0.70	0.00	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	8.41	0.93	9.34	0.93	0.00	1.87	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.37	4.64	3.09	3.61	1.03	1.03	1.03	6.70	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	9.52	2.38	8.33	1.19	1.19	1.19	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.93	9.50	2.49	9.95	0.90	1.36	3.39	4.07	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	9.89	3.49	8.72	0.29	1.45	3.20	3.78	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	8.10	3.60	5.85	0.90	3.15	2.25	4.05	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.94	12.19	2.85	8.54	1.63	1.22	2.98	5.42	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.84	11.30	2.05	8.73	0.00	1.03	0.51	5.14	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.82	10.23	2.47	7.06	1.41	1.76	3.18	7.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	9.33	2.00	9.99	2.67	3.33	1.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	9.17	1.53	13.24	2.04	2.04	4.08	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.88	13.07	3.74	9.34	1.60	0.80	0.53	6.40	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.30	10.96	2.27	9.07	0.19	1.13	3.02	4.53	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.11	4.91	1.84	6.75	1.84	0.00	0.61	8.59	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	5.71	1.63	7.34	0.82	0.82	1.63	5.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.24	11.45	2.08	9.58	1.67	2.50	4.37	4.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.90	15.69	1.68	10.09	0.56	1.96	3.08	3.64	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	17.52	5.15	10.30	1.03	1.03	0.00	5.15	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.45	14.52	2.32	9.00	1.16	1.16	1.45	4.94	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.35	11.36	4.19	7.77	0.90	2.69	2.99	4.19	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	12.17	2.21	10.51	0.55	0.55	2.77	6.09	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.49	12.73	2.47	10.25	0.35	0.71	2.47	2.47	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	17.33	10.33	1.84	5.90	1.11	1.48	2.21	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	16.12	0.00	4.61	2.30	0.00	2.30	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	10.75	2.69	9.59	1.54	1.92	2.30	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	8.49	0.57	9.06	0.57	0.00	1.70	3.40	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.13	8.20	2.46	8.20	0.00	1.64	4.10	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	12.20	1.36	12.20	0.45	0.00	1.81	5.42	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.77	8.62	2.87	10.05	1.44	1.44	4.31	2.87	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	8.22	2.99	10.46	0.00	0.00	4.48	6.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.66	13.01	2.23	6.69	0.37	2.60	1.49	2.60	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.95	12.06	1.72	9.48	1.72	0.86	0.86	6.46	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	10.28	1.71	5.14	1.71	1.71	5.14	4.28	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.33	10.33	2.67	8.66	1.00	1.00	3.66	4.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	11.46	1.21	6.64	0.60	0.60	2.41	3.62	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	12.09	0.00	3.55	0.71	1.42	2.13	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.28	11.69	1.03	8.59	0.69	2.41	2.06	3.09	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.71	12.88	1.61	8.05	0.54	1.07	4.29	3.22	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	10.77	1.35	4.71	0.67	0.67	2.02	4.04	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.89	11.85	2.96	8.15	1.48	1.11	1.48	4.44	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	16.28	5.81	10.47	1.16	1.16	3.49	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	8.46	2.12	8.46	0.00	6.35	1.06	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	14.81	2.00	8.40	0.40	1.60	1.20	4.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	13.81	0.73	5.81	1.45	1.45	1.45	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	12.26	3.83	9.96	0.00	1.53	2.30	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	10.85	1.48	9.87	0.49	0.49	2.47	5.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	7.53	1.88	6.59	2.82	0.00	2.82	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.08	7.54	1.51	6.54	0.50	1.01	2.51	4.53	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.17	7.66	1.35	4.96	1.35	0.45	1.80	4.06	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	12.05	3.44	3.44	1.72	0.00	3.44	6.88	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.48	12.02	3.12	10.69	0.89	2.23	3.56	5.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.12	8.21	1.56	11.34	0.39	2.35	3.13	5.87	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	8.58	1.32	6.60	0.66	0.00	0.66	3.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.42	8.30	2.59	6.75	1.56	0.52	3.63	3.63	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.13	12.69	3.06	10.50	0.88	1.31	3.50	5.69	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	7.27	2.24	7.83	0.00	2.24	3.91	6.71	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.69	11.92	2.21	9.27	1.32	1.77	3.97	6.62	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.11	10.80	1.93	6.56	0.77	0.77	1.93	4.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.18	12.66	1.52	8.61	2.03	1.01	1.01	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.46	12.02	2.88	11.53	1.44	2.40	4.33	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.70	9.54	1.19	8.75	1.59	0.40	3.18	5.96	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.37	8.51	1.82	10.33	0.61	1.22	2.43	5.47	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	14.53	6.23	1.38	3.46	0.00	1.38	4.15	4.84	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.88	12.16	4.18	11.40	0.38	1.52	2.28	7.22	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.72	13.43	3.61	8.26	1.03	0.52	4.13	2.58	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	6.05	3.02	3.63	0.60	0.00	3.02	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.41	14.26	2.85	11.41	0.95	0.63	2.22	4.12	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.19	8.53	2.67	6.93	0.00	0.53	1.07	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	6.90	1.72	8.62	0.00	1.15	1.15	6.32	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	14.91	2.57	6.69	1.54	1.03	3.09	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	11.32	4.24	7.78	0.00	0.00	4.24	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	10.21	1.70	8.51	0.57	3.40	2.27	5.11	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	12.48	2.08	6.66	0.83	1.66	2.91	4.16	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	13.31	1.57	10.18	0.00	0.00	3.13	5.48	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	10.86	2.09	8.35	0.84	1.67	1.67	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.94	13.01	3.25	6.50	0.93	1.39	5.11	3.25	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	16.06	0.67	6.69	1.34	0.00	2.01	5.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.04	12.83	4.28	8.02	0.00	1.60	0.53	4.81	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.57	14.14	1.21	7.68	0.81	1.62	2.42	2.83	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	13.77	1.84	7.34	0.92	4.59	2.75	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	8.89	5.33	8.89	0.89	0.00	0.89	4.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	18.81	2.85	7.98	1.71	1.71	3.42	2.85	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	11.50	0.77	9.20	0.77	2.30	2.30	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	12.04	0.55	9.30	0.55	3.28	3.28	4.38	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.35	11.14	1.78	8.46	0.00	1.78	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.52	12.74	4.42	10.14	1.82	2.08	3.12	3.12	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	10.61	9.28	3.32	3.32	1.99	1.99	2.65	4.64	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	12.47	0.00	6.24	0.00	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.17	2.73	8.43	1.60	1.37	0.23	2.73	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	9.36	3.49	8.62	5.14	1.47	0.55	1.28	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	6.29	2.75	6.03	2.49	0.79	0.66	1.97	0.66	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	3.19	2.12	1.06	0.00	0.53	1.06	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	6.81	5.23	2.69	1.27	1.11	0.63	1.27	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	9.03	3.75	0.69	2.36	1.53	0.83	0.56	1.11	0.00
Mammary Epithelial Cell, donor1	11273-116H4	9.37	8.67	3.89	7.47	0.10	0.80	1.40	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	7.53	5.79	2.03	4.34	0.29	2.32	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	1.25	0.75	0.00	0.25	0.50	0.50	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	10.17	16.95	5.42	6.78	0.68	0.68	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	18.49	5.84	4.00	11.68	1.73	1.19	1.41	0.76	0.00
Mast cell, donor2	11565-120D8	13.37	10.70	7.73	5.35	5.94	0.89	1.19	0.30	0.00
Mast cell, donor3	11566-120D9	13.28	15.98	11.03	4.73	3.15	0.90	2.03	0.90	0.68
Mast cell, donor4	11567-120E1	10.28	10.81	11.70	4.08	6.21	0.53	1.60	1.06	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	19.85	4.55	6.43	9.76	1.55	0.55	0.89	0.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	14.59	6.42	11.67	0.00	0.58	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	15.14	2.06	3.21	3.33	1.49	0.46	1.15	1.72	0.11
Mast cell, expanded, donor8	11941-126A6	11.05	4.18	6.86	3.85	1.67	0.50	0.84	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	5.57	1.39	1.59	1.19	0.00	0.20	0.80	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	4.50	2.08	0.00	0.69	0.35	0.69	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	2.54	3.11	1.67	0.36	0.43	0.58	0.65	0.14	0.07
Melanocyte - light, donor1	11274-116H5	0.94	1.18	0.94	0.00	0.24	0.00	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.68	1.36	0.68	0.00	0.00	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	0.00	4.34	1.73	0.00	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	2.39	2.81	1.25	0.10	0.42	0.21	0.10	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	4.03	1.61	1.34	1.34	0.27	0.81	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	1.87	4.29	2.68	0.54	0.54	0.80	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	3.72	6.33	1.74	1.36	0.12	0.62	0.50	0.12	0.00
Meningeal Cells, donor2	11573-120E7	3.52	2.20	1.76	1.32	0.00	1.32	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	4.97	8.39	0.90	1.47	0.57	0.73	0.73	0.41	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.98	4.56	2.00	3.14	0.86	1.43	1.14	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	6.44	2.52	0.40	4.23	0.81	0.20	0.40	0.81	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2.15	5.74	2.15	0.72	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.14	5.51	0.64	1.69	0.21	1.06	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	2.51	0.00	1.51	0.00	0.00	1.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2.64	1.54	1.10	0.88	0.22	0.66	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	4.38	0.73	0.73	0.00	2.92	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2.05	2.66	0.61	0.41	0.00	0.82	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.71	1.66	1.39	2.08	0.83	0.28	0.83	0.97	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.49	0.37	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	4.08	3.82	1.32	1.84	0.39	0.79	0.39	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	2.97	0.89	0.89	0.30	0.30	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.84	2.56	1.28	0.64	0.00	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.73	3.90	2.48	3.19	0.35	0.35	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	3.44	2.50	0.00	1.88	0.63	0.94	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.08	2.90	1.45	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	3.45	1.86	0.27	2.39	0.80	1.06	0.00	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	2.50	1.50	0.50	0.00	0.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	3.40	3.04	0.79	1.81	0.43	0.87	0.51	0.43	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	9.45	13.50	1.35	2.70	2.70	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	5.91	1.97	5.66	4.19	1.23	0.00	0.99	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.89	4.12	5.59	4.71	2.06	0.88	2.06	0.29	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	3.46	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.30	1.24	4.34	4.03	1.55	0.62	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.85	4.15	8.71	2.90	1.04	0.62	0.62	0.41	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	2.32	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.76	1.50	4.75	3.50	0.75	1.00	1.75	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	3.72	14.43	3.26	2.33	0.93	1.40	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.83	2.44	6.50	2.44	1.63	0.81	0.81	1.22	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	6.34	12.67	6.73	0.40	1.19	1.19	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	25.65	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	6.19	5.31	2.65	0.00	0.00	0.88	4.42	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.26	4.94	9.12	5.32	1.52	0.00	1.14	2.28	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	2.63	2.63	2.63	1.32	0.00	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.28	3.40	8.06	6.58	1.91	0.21	1.70	2.76	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	1.84	8.29	4.60	0.00	0.00	0.92	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.41	5.96	9.24	8.35	2.38	0.89	1.49	3.28	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	10.06	10.06	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.81	5.52	10.54	5.02	3.51	0.25	0.75	1.76	3.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	4.28	15.92	7.61	0.71	0.48	0.95	1.19	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	8.29	11.06	0.00	4.98	0.00	0.00	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.72	8.75	11.97	6.22	3.91	0.69	1.84	2.76	3.22
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.41	7.57	16.62	7.15	1.47	0.63	2.31	1.47	4.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.92	13.05	18.75	6.11	3.47	1.43	2.04	1.83	4.08
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.09	4.51	12.66	6.65	3.22	1.07	1.72	1.93	2.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.34	13.34	20.45	6.45	1.56	0.67	1.11	1.56	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.18	11.17	11.17	5.69	3.94	1.31	2.19	2.19	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	16.22	24.84	7.10	3.04	1.01	3.55	3.04	2.53
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	11.60	9.94	1.66	0.00	0.00	0.00	0.00	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.67	13.05	13.05	4.62	2.72	1.90	1.36	3.26	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.53	11.47	25.59	8.82	1.76	1.76	0.88	1.47	8.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	18.54	18.54	3.27	2.18	3.27	0.00	1.09	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	8.17	13.46	4.32	2.40	2.88	0.48	1.92	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	14.01	19.61	6.00	3.60	0.00	2.40	3.20	4.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	38.39	30.17	10.97	1.37	4.11	0.00	0.00	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	14.52	11.51	8.51	3.00	2.00	0.50	2.00	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	22.42	16.31	0.00	0.00	6.12	0.00	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	31.09	7.88	19.27	7.01	2.63	1.31	4.82	3.50	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	12.14	18.76	1.10	7.73	1.10	2.21	2.21	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	19.85	33.94	2.56	3.20	1.92	0.64	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.31	10.91	20.33	6.69	4.21	0.99	1.49	3.47	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	9.05	11.83	3.48	3.48	2.78	0.70	1.39	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	24.31	17.68	6.63	2.21	4.42	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.49	8.21	12.65	3.08	1.71	1.03	2.05	3.08	3.08
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	9.19	24.07	3.94	2.63	0.44	1.75	0.88	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	16.33	12.78	2.84	2.13	4.62	1.07	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.77	7.29	14.03	3.93	3.93	0.56	1.40	2.81	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	15.38	5.82	17.87	2.49	1.25	1.25	1.66	1.66	4.57
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	9.32	20.40	0.58	2.91	4.08	1.75	1.75	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.27	8.14	12.67	5.13	2.71	0.30	2.11	1.21	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	18.37	4.59	18.78	4.59	1.25	1.25	5.43	2.09	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	14.44	0.00	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	5.54	12.93	0.92	1.85	0.00	0.92	1.85	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	9.11	25.04	2.85	3.41	1.14	3.41	2.28	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.23	8.57	9.67	1.38	3.04	1.24	1.52	0.83	2.21
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.40	3.37	11.66	3.63	2.59	0.52	4.15	1.30	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	4.72	22.74	2.57	0.43	2.14	1.72	1.29	5.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	8.26	10.16	0.64	3.81	2.54	0.64	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.21	4.00	9.34	2.40	4.27	0.27	0.80	1.60	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.86	5.69	11.67	5.09	2.10	0.30	1.50	1.20	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.87	6.92	7.63	1.70	1.84	2.12	1.27	1.27	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.93	3.19	7.96	3.19	4.46	1.27	2.87	1.27	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	22.11	4.42	22.78	3.10	1.77	1.33	2.87	3.32	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	9.86	13.65	0.38	2.28	3.79	0.76	0.76	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	3.13	10.23	1.70	3.69	0.85	1.99	2.56	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.33	4.18	15.49	4.67	0.49	0.98	4.18	2.46	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	9.78	10.43	0.65	3.91	0.65	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.99	2.94	6.17	1.18	2.06	0.59	2.94	1.18	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.66	5.77	17.30	4.90	2.31	0.86	2.59	3.46	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.43	9.07	11.95	2.47	2.47	1.65	1.65	1.24	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.57	3.28	5.96	4.17	3.28	0.00	2.98	3.87	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	3.77	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	5.35	0.00	5.35	5.35	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.86	2.30	3.94	1.97	1.97	0.33	0.99	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	1.05	2.10	3.16	1.05	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.87	1.78	2.37	3.56	1.19	0.40	2.97	1.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	1.86	2.79	0.93	0.00	0.00	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.14	1.88	3.38	2.25	1.13	1.50	1.13	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.59	2.40	2.93	2.93	0.53	1.86	0.80	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	13.46	2.38	3.62	1.92	0.68	0.68	1.24	0.79	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	0.00	3.68	1.47	1.47	0.00	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.23	0.73	1.83	1.10	2.20	0.37	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	1.56	3.11	0.00	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.45	3.21	12.83	3.74	2.14	1.07	1.07	2.14	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	7.73	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	3.03	2.02	1.01	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.17	2.53	4.64	4.22	0.84	2.53	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	8.17	13.62	1.36	2.72	0.00	4.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	1.91	15.89	4.45	0.00	0.64	2.54	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	16.20	2.43	14.58	3.24	1.62	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	6.04	15.10	4.53	0.00	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	34.26	5.71	5.71	5.71	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	9.79	6.52	6.52	0.00	0.00	0.00	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	14.26	4.75	9.50	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	25.10	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.52	8.19	2.15	1.08	0.00	0.86	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	2.09	4.18	1.57	1.05	0.52	1.05	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	2.67	2.00	0.00	0.67	0.67	0.00	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	1.67	2.92	0.00	0.83	0.00	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.13	3.61	1.90	2.66	0.76	0.95	3.80	1.14	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	7.98	7.98	1.60	0.00	0.00	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	1.36	0.00	1.36	0.00	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	5.51	1.84	5.51	1.84	5.51	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.51	2.93	0.00	0.42	0.00	1.67	2.93	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	1.86	2.56	0.70	1.16	0.23	0.23	1.86	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	3.51	0.54	0.54	0.27	0.54	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	3.36	2.73	0.84	0.63	0.63	0.21	1.47	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	22.27	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	0.99	1.99	1.49	0.00	0.50	0.99	1.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	1.08	0.81	1.62	0.27	0.27	1.08	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.49	1.59	0.68	0.00	0.23	0.23	1.36	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1.14	1.96	1.31	0.49	0.16	0.00	1.14	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	4.01	3.28	0.55	1.46	0.00	0.73	1.09	0.91	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.18	2.65	2.12	1.06	0.00	0.00	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	1.20	0.60	0.60	0.00	1.20	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.16	3.94	2.30	1.97	1.31	0.98	6.56	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.98	0.98	0.65	0.33	0.00	0.81	0.81	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	3.17	3.53	1.06	0.53	0.88	0.88	0.35	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	2.81	0.00	1.41	0.70	0.00	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.38	3.22	0.46	0.46	0.92	0.92	3.22	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.89	1.29	0.64	0.64	0.00	0.32	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.24	3.79	1.38	2.07	0.34	0.00	5.52	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	15.17	12.64	2.53	2.53	7.59	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2.67	4.46	1.56	1.11	0.22	0.22	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	3.39	2.12	1.27	1.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.98	3.32	0.47	0.24	0.24	0.00	1.66	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.86	2.15	0.86	0.43	0.00	1.29	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.33	2.00	0.33	0.67	0.33	0.67	2.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	0.45	5.41	2.25	0.45	0.90	0.45	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1.59	1.98	0.79	1.59	0.00	0.00	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	1.86	0.93	0.00	0.00	0.00	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.78	3.03	1.14	0.76	0.00	0.38	1.89	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.28	2.93	1.30	0.65	0.00	0.33	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.18	1.74	1.74	0.44	0.00	0.44	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	3.62	4.98	3.17	0.00	0.45	0.45	0.90	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.88	1.76	0.00	0.88	0.00	2.65	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	2.66	1.33	0.00	0.00	1.33	1.99	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	4.96	1.49	1.49	0.50	0.00	1.49	1.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.30	1.53	1.91	0.00	0.00	0.77	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	4.84	0.60	0.60	1.21	0.60	0.30	2.12	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	4.64	2.65	1.77	2.21	0.22	0.22	0.44	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	2.03	0.68	0.68	0.00	0.00	0.00	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	2.44	1.22	0.00	1.83	0.00	0.61	3.05	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	1.57	1.26	0.31	0.94	0.94	0.94	1.26	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1.51	2.72	1.21	0.30	0.61	0.30	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.79	0.00	1.58	0.00	0.00	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	3.40	2.27	3.40	1.13	0.00	5.67	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	5.06	5.06	15.17	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.84	2.48	1.37	2.11	0.50	0.37	0.75	0.75	0.50
Myoblast, donor2	11322-117D8	2.88	4.22	0.96	1.73	0.58	0.96	0.19	0.77	0.00
Myoblast, donor3	11398-118D3	4.37	3.03	2.02	1.85	0.84	1.01	0.34	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	4.38	2.33	1.31	3.21	0.58	0.44	0.44	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	44.90	27.37	13.53	15.68	4.00	0.31	0.31	1.23	0.62
Natural Killer Cells, donor2	11311-117C6	30.76	20.51	7.24	12.36	3.92	0.90	0.30	1.51	0.90
Natural Killer Cells, donor3	11387-118C1	41.04	25.22	9.39	12.70	3.31	0.55	0.74	2.02	0.18
Neural stem cells, donor1	11275-116H6	6.53	17.42	0.73	2.54	0.00	3.63	2.54	0.36	0.00
Neural stem cells, donor2	11352-117H2	0.00	15.41	0.00	0.00	0.00	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	3.41	9.10	1.14	0.00	0.00	2.28	0.00	0.00	0.00
Neurons, donor2	11574-120E8	2.20	4.62	0.88	0.44	0.22	1.76	0.44	0.44	0.00
Neurons, donor3	11655-122E8	0.00	1.64	0.00	1.64	0.82	1.64	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	51.97	32.48	2.78	10.21	23.20	0.93	8.35	0.93	0.93
Neutrophils, donor2	11314-117C9	31.89	14.49	2.90	5.80	23.19	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	89.18	36.65	1.83	9.16	25.66	2.44	14.66	7.94	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	5.94	3.80	0.47	1.78	0.24	1.19	0.59	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	4.23	4.23	0.65	2.60	0.00	1.30	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	4.41	3.01	0.20	1.40	0.40	0.80	1.00	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	1.79	1.93	0.96	0.55	0.00	0.41	0.96	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	7.09	3.04	1.01	1.74	0.00	0.72	1.30	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	2.84	1.82	1.70	1.36	0.34	0.45	0.34	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	2.43	1.66	0.68	0.97	0.49	0.39	0.39	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	6.62	3.01	0.60	0.60	0.00	0.60	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	3.40	2.13	0.21	3.40	0.64	0.21	1.06	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	1.14	1.14	2.29	1.14	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	3.10	4.97	0.00	1.24	0.00	0.62	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	2.35	2.74	0.00	0.39	0.59	0.59	0.59	0.00	0.00
Osteoblast, donor2	11354-117H4	11.94	7.02	0.00	4.92	0.70	0.70	1.40	0.70	0.70
Osteoblast, donor3	11426-118G4	6.04	5.15	0.53	2.49	1.07	1.07	0.71	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.68	4.72	2.36	2.53	0.84	0.76	1.18	0.84	0.00
Pericytes, donor1	11491-119E6	1.34	2.45	0.45	0.33	0.22	0.33	0.22	0.11	0.00
Pericytes, donor2	11571-120E5	1.36	3.40	0.23	0.23	0.45	0.68	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	1.83	3.05	1.02	0.20	0.20	0.20	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	7.01	3.50	1.47	1.58	0.23	0.23	1.24	0.23	0.00
Perineurial Cells, donor2	11579-120F4	6.26	4.14	0.46	3.04	0.74	0.92	0.64	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	40.48	20.08	7.01	13.39	4.46	0.64	0.96	0.32	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.63	19.10	6.37	4.90	2.69	0.49	1.96	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	32.10	15.14	5.95	6.99	3.36	1.04	0.91	1.68	1.16
Placental Epithelial Cells, donor1	11278-116H9	1.91	0.96	0.00	0.48	0.24	0.24	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	1.11	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	1.57	2.55	1.57	1.18	0.20	0.20	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.58	0.00	0.95	0.32	0.63	0.00	0.32	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	4.13	3.75	2.06	1.50	0.38	0.19	0.00	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2.87	1.57	3.79	0.52	0.26	0.13	0.52	0.39	0.52
Preadipocyte - breast, donor2	11328-117E5	2.03	1.35	1.58	0.90	0.00	1.58	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	4.05	2.34	2.02	0.85	0.85	0.32	0.43	0.85	0.21
Preadipocyte - omental, donor2	11329-117E6	5.24	1.75	1.75	1.75	1.31	0.00	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	2.72	4.15	1.58	0.86	0.29	1.00	0.72	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	0.98	0.98	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.76	1.84	0.61	0.92	0.00	0.61	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	6.91	4.60	2.30	3.19	0.53	1.06	0.71	0.00	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	4.60	6.81	1.70	3.07	0.51	1.87	0.85	0.17	0.34
Preadipocyte - visceral, donor1	11280-116I2	8.20	4.56	2.79	2.79	0.47	1.77	0.84	0.84	0.00
Preadipocyte - visceral, donor2	11357-117H7	6.90	6.44	1.38	1.38	1.38	1.38	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	5.02	3.76	1.99	1.67	0.21	0.84	0.52	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2.87	14.48	1.81	1.66	0.75	1.21	0.60	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	2.57	3.11	1.22	0.41	1.35	0.54	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	4.16	4.65	4.16	1.04	0.67	0.67	1.71	0.80	0.06
Prostate Stromal Cells, donor1	11254-116F3	5.81	4.33	1.59	1.71	0.46	1.25	0.46	0.57	0.34
Prostate Stromal Cells, donor2	11332-117E9	5.02	4.66	1.61	1.43	0.54	0.90	0.36	0.54	0.18
Prostate Stromal Cells, donor3	11405-118E1	4.28	2.29	0.52	0.52	0.31	0.21	0.63	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	1.09	2.92	0.00	0.36	0.00	0.73	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.78	4.30	1.39	1.52	0.49	1.25	0.83	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	1.01	2.54	1.01	0.00	0.00	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	5.69	0.71	0.00	0.00	2.13	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	7.09	5.93	0.74	2.33	0.42	0.85	1.69	0.42	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.68	0.68	0.00	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.83	1.08	0.54	1.21	0.54	0.81	0.27	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	6.66	5.55	1.55	2.00	0.00	0.89	0.44	1.11	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.00	2.66	0.67	0.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	1.10	3.74	1.10	0.44	0.00	0.00	0.22	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	1.25	1.88	0.63	1.25	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.28	2.50	0.00	0.55	0.00	1.11	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	4.56	4.83	2.95	1.34	0.81	0.27	1.07	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	0.84	2.53	0.42	0.00	0.42	1.69	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1.74	2.89	0.39	0.19	0.19	0.77	0.19	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2.07	4.67	0.78	1.04	0.52	0.00	0.26	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	2.56	3.13	0.28	1.14	0.28	1.42	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.52	5.52	0.50	1.00	0.25	0.75	0.75	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.36	4.81	9.89	4.14	2.00	1.07	2.54	1.87	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1.79	5.36	0.89	0.89	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	7.15	0.55	1.65	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3.48	9.28	1.74	0.00	1.74	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	3.51	5.72	1.69	1.17	0.39	1.04	0.26	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1.99	6.45	0.79	0.70	0.50	0.60	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	2.45	5.69	1.00	0.22	0.45	1.12	0.22	0.22	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	3.97	4.71	1.36	0.99	0.50	0.62	0.50	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	1.63	7.23	1.05	0.23	0.82	0.93	0.23	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	2.54	5.08	0.69	0.46	0.69	0.92	0.69	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1.78	4.79	0.96	0.55	0.14	0.55	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1.82	6.81	0.76	0.30	0.30	1.21	0.45	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	1.61	5.38	1.43	0.54	0.00	0.72	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	0.86	5.74	1.00	0.72	0.29	0.43	0.43	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	1.72	6.44	0.86	0.11	0.43	1.18	0.54	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	0.89	4.20	1.55	0.44	0.00	0.66	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1.34	6.69	0.76	0.76	0.19	0.19	0.00	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	2.42	7.55	1.02	0.47	0.56	1.12	0.19	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	3.76	9.02	1.32	0.56	0.56	0.75	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1.86	5.71	1.59	0.53	0.40	1.86	0.13	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1.36	6.23	1.07	0.49	0.10	0.97	0.19	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2.86	6.49	0.95	1.15	0.19	1.15	0.95	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1.28	6.73	1.17	0.21	0.53	0.85	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	3.08	7.85	1.12	0.28	0.28	1.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	2.22	7.35	0.68	0.68	0.00	1.03	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1.28	5.11	1.64	0.36	0.00	1.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1.35	7.60	0.49	0.49	0.49	0.98	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	1.21	5.91	0.54	0.40	0.00	0.67	0.13	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1.18	4.48	0.71	1.18	0.71	0.24	0.94	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1.98	6.75	0.60	0.20	0.40	1.59	0.60	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1.17	5.85	1.17	0.47	0.70	0.70	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1.24	6.01	0.41	1.04	0.00	1.45	0.41	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1.99	6.64	0.88	0.66	0.44	0.44	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	2.30	4.80	1.04	0.21	0.63	0.63	0.42	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	0.94	7.40	1.21	0.67	0.13	1.08	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	0.51	7.32	0.68	0.34	0.17	1.19	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	2.70	8.10	0.19	1.16	0.00	0.58	0.19	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2.58	4.81	0.69	0.69	0.34	0.34	0.69	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	2.61	8.92	1.37	0.82	0.55	1.10	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	2.79	6.07	1.15	0.66	0.82	0.82	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1.87	5.45	1.53	0.34	0.17	0.68	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1.18	7.25	0.59	0.89	0.44	1.78	0.30	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1.87	7.73	0.80	0.53	0.27	0.80	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	0.83	9.26	1.24	0.41	0.69	1.11	0.41	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1.90	5.24	1.43	0.48	0.00	0.24	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	2.22	5.84	2.02	0.60	0.40	0.81	0.20	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1.88	5.27	1.88	0.75	0.19	0.94	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	3.49	11.18	1.75	0.00	0.00	1.05	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1.51	7.25	1.51	0.30	1.51	1.21	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2.20	6.00	1.84	0.61	0.61	0.49	0.49	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	4.08	15.28	4.08	1.02	0.29	1.89	0.44	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	2.43	11.56	0.61	0.61	0.61	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2.71	5.12	0.30	1.21	0.00	0.00	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2.49	9.05	2.94	0.68	0.45	0.68	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	3.29	8.99	2.10	0.60	0.00	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3.07	8.74	3.78	2.72	0.35	1.06	0.00	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1.71	9.39	1.49	1.28	0.00	1.28	0.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	5.41	7.81	5.41	1.20	0.60	1.20	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	0.56	4.89	0.19	0.00	0.56	1.32	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	3.72	6.13	0.66	0.22	0.22	0.88	1.10	0.00	0.00
Sebocyte, donor1	11220-116B5	1.64	6.57	2.19	0.55	0.55	0.55	1.64	1.10	0.00
Sebocyte, donor2	11301-117B5	0.00	3.68	2.30	0.46	0.46	0.46	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	1.44	1.03	0.82	0.82	0.21	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	8.28	3.31	1.66	3.31	1.66	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	2.82	0.00	0.00	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.30	10.73	2.11	2.55	0.26	1.76	0.88	0.26	0.09
Skeletal Muscle Cells, donor2	11358-117H8	2.17	2.17	0.72	1.45	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	0.00	0.00	0.84	1.67	0.84	0.84	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	6.76	4.56	1.41	1.89	0.31	1.10	0.47	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	2.97	3.42	0.15	2.08	0.00	0.59	0.59	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	3.85	4.77	1.23	2.15	0.92	1.08	0.31	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	10.96	3.91	2.52	3.65	0.25	0.63	1.89	1.01	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	6.14	4.99	0.86	1.71	0.43	0.86	1.00	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	2.98	8.23	1.39	1.79	0.10	1.09	0.50	0.10	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.84	8.00	2.61	5.06	0.34	1.01	0.84	0.93	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.90	2.90	0.72	0.72	0.72	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.30	2.48	0.41	1.38	0.28	0.14	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	0.00	5.37	2.69	2.69	2.69	2.69	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.74	2.59	0.29	0.29	0.58	0.58	0.58	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	5.73	9.00	6.54	0.82	5.73	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	1.04	3.12	0.26	0.39	0.65	0.52	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.48	7.37	3.06	4.87	0.56	1.25	1.25	1.53	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	4.08	7.17	1.97	1.97	1.13	1.69	0.14	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	4.23	11.00	7.19	2.54	2.54	1.69	0.00	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	4.27	11.99	3.45	1.80	2.02	2.62	0.52	0.75	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.39	2.16	1.54	2.78	0.31	0.00	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3.33	0.00	4.45	0.67	0.00	0.00	0.89	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	4.11	1.76	1.18	0.00	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.09	2.21	0.88	0.66	0.22	1.10	0.88	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.76	1.97	1.18	0.39	0.79	0.79	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	1.55	0.77	0.00	0.00	0.77	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	6.00	5.00	1.00	0.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.66	2.00	0.93	0.67	0.40	0.67	0.27	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	4.88	2.66	1.11	1.11	0.00	0.44	1.11	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.99	1.28	0.51	1.54	1.15	0.26	0.26	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	3.91	2.93	1.63	0.65	0.65	0.65	1.30	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	3.54	2.66	1.18	1.48	0.30	1.18	0.59	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	2.70	2.42	1.14	0.57	1.14	0.85	0.71	0.71	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.14	2.77	0.33	0.00	0.33	0.81	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.26	3.04	2.74	1.83	0.91	0.61	0.30	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	2.53	1.77	0.76	1.01	0.00	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	0.48	1.91	0.95	0.00	0.48	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5.16	2.51	1.18	1.62	0.15	0.74	1.03	0.88	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4.95	3.01	0.86	1.29	0.43	0.65	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	4.20	4.09	1.36	1.36	0.73	0.84	0.52	0.63	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.17	1.70	0.77	0.93	0.62	0.31	0.46	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	0.00	0.00	1.08	0.00	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.69	0.90	0.90	0.60	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	0.34	1.71	0.68	0.00	0.00	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	4.79	3.53	1.10	1.65	0.63	0.55	0.79	0.55	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.94	2.82	0.81	1.91	0.70	0.30	1.01	0.50	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.01	3.19	1.82	1.14	0.91	0.46	0.46	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	0.60	0.00	0.60	0.00	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	6.89	4.50	0.79	0.53	0.79	1.32	0.53	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6.92	3.86	1.60	2.53	0.67	0.93	0.80	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.63	5.01	1.50	2.63	0.13	1.13	1.25	1.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.58	2.79	0.76	0.25	0.00	0.25	0.76	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	6.33	3.92	1.21	1.96	0.90	0.45	0.45	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	2.25	1.50	0.00	0.00	0.75	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	0.00	0.00	1.29	5.17	0.00	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2.79	2.33	0.93	1.40	2.79	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.52	0.50	0.50	1.01	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	2.19	1.25	0.00	0.94	0.63	0.31	0.63	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.59	1.18	0.00	0.29	0.00	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	5.17	5.91	1.08	2.25	0.50	1.42	0.75	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	4.20	0.93	1.87	0.93	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.01	2.01	0.29	1.15	0.58	0.29	0.43	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.59	3.06	0.25	1.27	1.02	0.25	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.13	2.26	0.56	0.75	0.19	0.75	0.38	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.66	4.89	1.96	2.93	0.28	0.98	1.82	1.82	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.64	6.28	1.68	2.68	0.34	1.09	0.84	1.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	0.24	0.98	0.98	1.22	0.98	0.73	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.74	2.43	0.44	3.76	0.88	0.66	0.66	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.27	2.05	0.59	2.05	0.88	0.29	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	3.30	2.53	0.97	0.00	0.39	0.00	0.78	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2.91	0.79	1.06	0.53	0.26	0.26	1.06	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	1.86	1.49	0.37	0.00	0.00	1.49	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.47	1.80	0.72	1.44	0.00	0.72	0.00	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.69	3.41	1.42	1.42	0.00	0.85	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	2.36	5.51	0.39	1.18	0.79	0.00	0.00	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	3.81	3.56	2.29	0.51	0.25	0.51	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.59	2.40	2.00	1.20	0.00	0.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	1.25	1.67	0.84	0.84	0.42	0.42	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	4.13	0.92	0.46	1.38	0.46	0.46	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	3.37	4.21	2.02	3.37	0.17	1.01	0.17	0.17	0.00
Synoviocyte, donor2	11368-117I9	9.89	4.02	1.68	1.84	0.17	0.17	1.01	0.50	0.17
Synoviocyte, donor3	11440-118H9	3.13	1.79	1.34	1.12	0.22	0.89	0.67	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	2.14	4.29	2.14	0.36	0.71	0.00	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	0.00	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	2.08	2.55	0.69	0.69	0.00	0.93	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	3.23	2.87	0.93	2.22	0.00	0.22	0.65	0.65	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	0.77	0.39	0.39	0.39	0.00	0.00	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	0.57	0.00	0.00	0.57	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	15.50	6.40	11.69	5.91	1.35	0.98	1.97	1.85	0.74
Urethra, donor2	10319-105A4	5.40	1.80	3.60	0.00	0.00	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	3.19	4.52	2.13	0.80	0.00	1.33	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	2.80	2.40	0.00	0.80	0.00	0.00	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	0.46	1.15	0.23	0.00	0.23	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	6.24	2.01	1.11	3.34	1.56	1.11	0.22	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.91	3.56	7.12	8.01	5.34	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	5.72	2.86	5.72	5.72	0.00	1.43	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	11.64	3.42	2.05	3.42	0.68	0.00	2.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	17.22	2.41	2.41	6.89	1.03	0.34	0.69	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.24	2.32	2.32	6.97	4.07	0.00	1.74	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	24.99	2.08	1.04	6.25	11.45	0.00	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	25.70	2.75	10.10	8.26	3.67	0.00	0.92	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.95	0.91	4.56	2.74	5.48	0.91	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	4.44	7.40	3.95	0.99	0.37	2.84	0.25	0.62	0.25
Wilms' tumor cell line:HFWT	10597-108E3	0.00	9.68	3.52	0.00	0.00	0.88	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	2.23	5.59	0.28	1.40	0.28	0.84	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	8.27	0.00	4.13	0.00	0.00	0.00	0.00	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	5.35	1.02	0.76	0.25	1.53	0.51	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.61	5.11	1.39	2.79	1.39	1.39	0.23	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	6.65	9.38	1.54	2.37	0.36	2.85	0.47	0.47	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.88	0.54	0.54	4.08	1.09	0.54	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	8.15	3.37	2.25	7.03	0.00	0.56	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.42	4.44	1.27	9.09	0.85	0.42	0.63	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	8.17	2.45	7.62	1.09	0.82	0.54	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	11.02	4.85	3.08	3.08	0.44	0.44	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	8.98	3.27	1.63	1.23	0.00	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	11.65	4.66	1.94	2.33	0.00	1.94	1.55	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.15	1.10	0.18	3.50	0.00	0.18	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	3.90	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.06	3.72	0.23	3.25	0.00	0.93	1.39	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.83	3.88	1.81	2.85	0.52	0.00	0.78	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	11.69	2.05	0.00	2.34	0.88	0.88	1.46	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	15.80	4.65	0.93	2.32	0.00	0.00	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.10	3.70	0.00	3.70	0.41	0.41	1.23	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.46	1.23	0.92	0.00	0.61	0.31	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.97	1.71	0.85	2.13	0.00	0.43	1.71	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.98	2.12	0.91	1.52	0.61	0.00	1.21	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.15	2.17	2.41	0.96	1.44	0.72	0.48	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.36	1.34	0.89	0.67	0.67	0.89	0.89	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	8.01	4.34	1.33	3.34	1.00	0.33	2.00	0.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	31.59	1.86	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.17	8.29	1.88	2.64	0.00	1.13	1.13	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	21.81	16.14	1.31	9.16	0.87	3.05	3.49	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	9.37	0.00	1.87	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	3.06	1.18	4.47	4.47	0.24	0.47	1.18	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	6.36	3.88	3.72	1.40	1.24	0.31	0.78	0.62	0.16
adipose, donor1	10184-103D4	16.42	15.25	0.00	5.86	0.59	0.59	2.35	1.17	0.00
adipose, donor2	10185-103D5	3.24	18.25	11.35	0.41	0.00	1.22	1.22	0.41	0.41
adipose, donor3	10186-103D6	5.99	14.70	2.72	2.45	0.54	2.18	1.91	1.91	0.27
adipose, donor4	10187-103D7	11.27	6.07	0.00	3.47	0.87	1.73	0.87	10.40	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.94	2.53	2.05	2.05	2.05	1.74	3.79	0.95	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.48	1.33	4.00	5.20	1.47	0.13	0.80	0.53	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	3.22	0.36	0.36	0.71	0.00	0.00	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	3.48	1.62	3.25	1.16	1.39	0.23	0.93	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	6.09	3.04	1.69	3.04	1.01	0.00	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	3.54	1.18	2.95	1.18	1.18	0.29	1.18	0.88	0.00
amygdala - adult, donor10196	10167-103B5	0.00	2.37	0.00	1.19	0.00	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	2.03	1.42	3.65	0.00	1.22	0.61	0.20	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	3.23	1.61	0.65	1.29	0.32	0.00	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	4.46	9.80	2.93	1.27	1.40	1.27	1.02	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	7.06	5.07	2.87	1.99	1.54	2.65	0.88	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.67	6.68	0.67	2.00	0.67	1.67	0.67	0.00	0.00
aorta, adult, pool1	10052-101G7	2.35	1.57	2.16	1.37	0.39	0.78	0.78	0.00	0.00
appendix, adult	10189-103D9	4.66	4.66	4.66	5.05	2.33	1.55	1.16	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.29	8.25	1.72	1.03	0.34	2.41	0.34	0.34	0.00
artery, adult	10190-103E1	2.72	2.72	10.87	0.00	1.36	0.00	0.00	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	4.35	6.66	3.33	2.61	0.58	1.45	1.01	0.00	0.00
b cell line:RPMI1788	10427-106D4	7.88	7.14	1.93	4.46	1.04	0.74	0.59	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.05	3.05	3.61	0.83	1.11	0.83	0.28	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	7.94	11.31	1.98	4.27	1.39	2.38	0.79	0.50	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	4.35	3.68	2.51	0.84	0.84	0.50	1.51	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	5.59	0.56	3.36	0.56	0.00	0.00	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	4.56	5.76	5.76	1.63	1.30	1.20	1.20	0.33	0.33
blood, adult, pool1	10053-101G8	13.29	6.64	0.00	4.43	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4.28	3.43	2.57	1.71	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	6.75	9.45	4.72	1.35	0.67	0.00	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	0.00	1.03	0.00	1.03	0.00	0.00	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	1.56	1.89	1.89	0.56	0.56	1.34	0.22	0.22	0.00
brain, fetal, pool1	10085-102B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	23.46	14.87	7.93	9.25	1.98	0.00	5.29	6.28	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	49.18	20.97	15.85	20.97	1.12	1.62	4.37	7.36	0.62
breast, adult, donor1	10080-102A8	2.53	0.63	1.89	0.63	0.63	0.00	1.26	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2.41	1.78	0.13	1.65	0.25	0.25	0.51	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1.55	7.11	0.62	0.62	1.24	1.86	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.20	7.60	3.45	3.22	0.92	0.92	1.84	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.84	6.29	3.39	1.45	0.24	0.48	2.18	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.94	3.76	0.00	0.47	0.94	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	1.64	8.86	0.66	0.44	0.77	1.31	0.33	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	0.32	1.90	0.00	0.32	0.32	0.95	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	0.80	5.32	0.53	0.53	0.80	1.33	0.27	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	0.00	1.15	3.45	0.00	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	1.17	2.34	3.18	2.34	0.67	1.00	0.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	2.29	1.53	2.29	0.76	0.76	3.06	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	2.93	4.03	0.73	0.73	0.73	0.00	1.10	1.83	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	2.91	0.00	8.74	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1.49	2.56	2.99	1.07	1.07	0.43	0.00	0.21	0.43
cerebellum, adult, pool1	10083-102B2	0.69	1.38	1.38	1.38	0.00	0.00	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	0.00	0.00	1.66	0.00	0.83	1.66	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	2.52	3.28	1.01	0.76	1.26	0.76	0.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	1.46	5.85	0.73	0.73	0.00	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	1.87	3.16	10.93	1.87	0.29	1.44	0.86	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	8.12	5.30	2.82	4.97	1.16	0.66	0.33	0.50	0.17
cervix, adult, pool1	10013-101C4	13.12	6.51	11.44	3.88	1.78	1.57	1.36	1.89	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.37	3.07	1.39	1.11	1.11	0.70	1.39	0.42	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	1.31	5.23	2.61	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.73	11.93	22.25	5.47	0.50	1.74	4.60	5.22	1.99
choriocarcinoma cell line:SCH	10785-110H2	6.53	6.16	3.45	1.48	0.25	0.86	0.86	2.34	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	8.54	3.79	12.33	0.47	1.90	1.66	2.13	1.90	0.24
chorionic membrane cells, donor1	12238-129G6	2.85	1.71	1.14	0.28	1.71	0.28	1.14	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	4.37	8.55	2.09	1.09	1.99	1.69	0.60	0.50	0.00
chorionic membrane cells, donor3	12240-129G8	6.04	2.75	1.65	1.10	2.75	1.10	1.10	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	0.00	1.01	1.01	0.00	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.72	1.34	1.15	1.15	0.38	0.19	0.19	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.60	2.75	0.00	1.06	0.21	0.21	0.84	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.60	7.70	3.34	1.80	1.03	1.03	0.26	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.39	6.77	0.24	1.69	1.21	0.97	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	4.89	6.52	1.83	2.65	0.81	2.04	0.20	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	6.18	5.59	2.65	2.06	1.18	0.59	0.29	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	8.60	4.43	1.04	2.61	1.04	1.04	0.26	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	4.57	4.34	1.60	2.06	0.69	1.14	1.37	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	4.34	2.26	0.35	1.21	0.87	0.35	0.87	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	7.32	8.42	0.55	2.75	0.00	2.93	0.92	1.46	0.00
colon carcinoma cell line:COLO-320	10420-106C6	5.70	16.34	4.18	3.04	0.76	1.52	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	5.95	0.00	2.38	0.00	0.00	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	2.12	2.70	5.52	1.76	3.64	0.59	1.65	0.47	0.71
colon, fetal, donor1	10070-101I7	7.42	0.62	3.09	2.47	0.62	0.62	4.94	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	13.75	0.00	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.12	3.40	8.92	7.22	1.70	1.70	1.70	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.43	2.72	2.41	6.04	0.75	0.15	0.91	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	14.52	1.69	3.67	9.73	0.42	0.42	0.99	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	1.88	4.64	4.09	0.66	1.00	1.44	0.22	0.33	0.11
cruciate ligament, donor2	10295-104G7	7.29	1.62	6.48	2.43	0.81	0.81	0.81	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	4.82	2.41	7.22	2.41	0.80	1.61	0.80	0.80	0.00
diencephalon, adult	10193-103E4	1.20	2.40	2.16	0.96	0.24	0.72	0.48	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.13	2.53	0.00	1.84	0.92	0.69	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	11.28	15.13	1.54	1.54	0.51	1.28	2.05	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	5.30	8.91	0.96	2.89	0.72	1.93	0.96	0.24	0.24
ductus deferens, adult	10196-103E7	2.99	1.00	3.99	2.49	0.50	0.00	1.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	4.32	7.20	0.00	0.00	1.44	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.24	3.68	5.89	1.47	0.74	1.47	1.47	2.21	0.74
dura mater, adult, donor1	10041-101F5	4.87	7.27	8.01	1.40	1.65	1.49	1.32	0.33	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.22	14.66	2.66	0.89	1.11	0.44	0.44	1.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	5.59	15.33	0.86	1.72	0.57	1.15	0.29	1.15	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	3.08	2.47	0.62	0.62	0.62	0.62	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	7.27	3.33	2.72	3.63	0.91	0.30	0.61	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.94	5.87	0.62	2.16	0.62	0.62	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	9.19	6.57	2.63	0.00	0.00	1.31	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	7.37	17.77	3.69	1.68	0.34	0.67	0.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.37	10.69	12.51	7.79	1.99	1.81	6.89	3.44	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.08	0.96	0.80	1.13	0.80	0.16	1.13	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	5.34	5.22	2.00	2.22	0.33	0.78	0.67	0.44	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	4.73	7.59	2.75	1.76	0.99	0.77	0.55	0.00	0.11
epididymis, adult	10197-103E8	10.05	8.79	7.33	2.72	1.26	0.63	1.05	3.35	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.44	3.90	1.24	2.31	0.00	1.77	0.71	0.35	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.97	3.93	0.00	0.79	0.00	1.57	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	8.39	4.72	3.15	4.72	0.66	0.39	0.52	1.31	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	7.28	6.59	3.44	3.94	0.79	0.69	0.69	0.79	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	9.97	4.48	3.02	5.04	0.45	1.23	1.01	0.67	0.00
esophagus, adult, pool1	10015-101C6	8.81	1.81	5.42	2.97	1.17	1.06	0.53	0.96	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.88	4.38	0.50	2.38	0.25	1.13	1.63	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	2.41	7.24	4.83	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	0.00	6.31	2.10	0.00	0.00	0.00	6.31	2.10
eye - muscle medial, donor2	10299-104H2	1.49	0.00	5.95	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	2.29	1.15	1.15	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	2.91	1.46	2.91	1.46	0.00	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	5.08	1.02	1.02	0.76	0.00	0.00	1.02	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	2.05	1.80	1.03	1.03	0.13	0.51	0.38	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	3.80	3.80	1.66	0.24	0.47	0.00	0.71	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	1.41	2.81	1.60	0.47	0.75	0.75	0.56	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.11	15.01	3.30	3.30	1.20	2.10	2.10	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	3.29	6.49	2.29	0.91	0.37	1.37	2.01	0.27	0.27
gall bladder, adult	10198-103E9	2.66	3.14	2.66	1.21	1.21	1.21	1.21	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	13.96	4.29	7.52	9.66	4.83	1.07	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	20.54	9.34	8.22	10.08	3.73	0.75	0.37	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	3.38	6.13	0.84	1.27	0.42	0.63	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.51	7.16	2.71	1.93	0.77	0.97	1.35	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	3.77	4.92	1.15	0.98	1.15	0.82	0.49	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	0.92	0.92	0.92	0.92	0.00	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.91	14.85	4.11	0.69	0.23	1.14	0.91	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	4.25	5.16	2.64	3.10	0.69	1.15	0.57	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	3.78	6.58	1.12	1.40	0.28	0.56	1.12	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.99	4.24	3.74	1.25	0.50	1.00	1.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	2.01	2.22	0.53	0.32	0.32	0.53	0.11	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	2.67	1.54	0.84	0.70	0.42	0.42	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	4.41	6.62	1.21	0.99	0.22	0.66	0.77	0.44	0.00
glioma cell line:GI-1	10413-106B8	2.34	4.98	0.88	1.46	0.59	0.29	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	1.46	0.73	2.19	1.46	0.73	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	2.93	2.93	10.25	0.98	0.98	1.46	1.22	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	0.00	2.74	2.74	0.00	1.37	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	5.86	1.07	1.07	0.00	1.07	0.00	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	17.13	2.45	0.00	7.34	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	1.92	6.40	0.32	0.64	0.32	0.32	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	11.48	32.14	4.59	1.84	0.00	3.21	0.46	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	9.15	26.52	4.12	1.37	0.00	2.74	0.91	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	11.59	24.48	7.73	1.29	1.29	2.58	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	8.62	5.75	0.00	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	10.29	13.72	0.69	0.00	1.37	3.43	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	2.21	2.21	2.21	1.10	1.10	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	13.51	3.45	0.57	5.46	0.86	0.00	0.86	0.00	0.00
heart - mitral valve, adult	10205-103F7	2.39	0.60	7.18	2.09	0.60	0.60	1.20	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	2.09	2.35	6.54	0.52	0.26	0.26	0.52	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	1.67	4.16	8.33	0.83	1.67	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	2.04	3.06	4.08	0.61	0.41	0.20	1.43	1.63	0.41
heart, adult, diseased, donor1	10051-101G6	2.55	1.28	7.24	0.43	0.43	0.00	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	2.30	1.61	8.97	0.46	1.38	0.69	0.46	0.00	0.46
heart, fetal, pool1	10046-101G1	4.21	7.19	12.94	1.13	0.41	0.92	0.72	0.00	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	3.09	3.39	1.23	1.23	0.31	0.93	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	2.38	13.08	0.00	0.00	1.19	0.00	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	6.41	10.28	2.98	3.20	0.33	1.33	0.88	0.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	5.95	10.68	5.10	2.43	0.12	1.70	0.73	1.58	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	4.75	12.13	5.05	3.44	0.51	1.21	0.51	1.01	0.20
hepatoma cell line:Li-7	10484-107A7	6.45	15.68	4.23	1.56	0.33	1.89	0.67	0.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.34	6.53	2.91	5.13	0.80	1.51	0.50	0.40	0.20
hippocampus - adult, donor10196	10169-103B7	0.00	0.95	0.95	0.00	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	3.06	2.65	2.86	0.82	0.82	1.22	0.82	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	1.49	1.99	1.49	0.00	1.00	0.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	0.70	2.82	0.35	0.35	0.00	1.06	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.70	11.60	0.61	3.66	0.00	4.88	1.83	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.48	6.87	1.37	1.18	0.98	1.77	0.79	1.37	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.89	7.62	0.25	1.78	0.51	2.79	1.02	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	6.77	6.77	0.00	1.69	0.00	2.26	2.26	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.61	9.55	0.26	1.55	0.00	3.10	1.03	0.77	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.56	8.73	0.76	0.76	0.76	2.66	2.28	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	7.01	12.26	2.04	0.88	0.88	2.63	1.46	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.95	15.30	4.31	2.59	0.65	0.65	1.29	1.08	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	4.17	7.92	2.92	2.92	0.00	1.67	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.87	12.55	2.37	2.13	0.71	1.42	1.42	1.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	6.11	11.25	2.25	2.41	0.80	2.41	0.96	1.45	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1.35	12.79	1.35	0.67	1.35	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.23	6.26	0.47	1.88	0.16	1.88	0.94	1.56	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.91	6.88	1.47	2.46	0.49	0.98	0.98	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.09	9.60	0.00	2.62	0.00	1.75	2.62	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.15	12.79	0.76	2.67	0.38	2.67	0.95	0.76	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.98	12.21	0.44	0.87	0.00	2.62	1.31	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.49	10.99	0.50	2.00	0.50	4.00	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.59	16.58	11.30	2.45	0.38	1.51	0.94	1.70	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.73	14.55	14.55	2.73	0.00	1.82	0.45	1.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.58	11.90	11.28	0.94	0.00	2.19	0.94	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.88	10.94	3.10	1.63	0.16	3.76	0.82	1.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.84	12.48	2.03	3.77	0.29	2.03	0.87	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.29	13.75	2.99	1.49	0.00	2.99	1.49	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.91	9.79	1.11	2.59	0.00	2.40	1.66	1.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.13	8.84	1.71	1.43	1.14	2.28	1.14	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.07	12.25	1.22	4.90	0.41	2.45	1.63	2.86	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	6.69	10.21	1.41	2.11	1.06	1.41	0.00	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.02	9.19	0.95	0.95	0.00	0.95	1.58	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.96	11.80	1.21	2.12	1.21	1.21	0.91	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	5.17	8.27	4.65	4.14	0.00	1.03	1.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	4.65	7.31	1.33	3.32	0.00	0.00	0.66	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.39	7.70	2.57	1.54	0.00	2.05	1.28	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.62	5.37	1.79	1.28	0.00	1.02	2.05	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	5.30	3.03	0.76	2.27	3.03	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.73	5.71	2.02	2.35	0.00	2.35	0.67	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.76	8.94	0.97	1.21	0.00	0.97	1.21	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.59	11.59	0.89	3.12	0.45	2.67	4.01	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.29	8.78	0.49	2.93	0.49	2.93	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.81	10.70	1.53	1.22	0.31	2.14	0.31	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	6.51	0.00	32.53	0.00	3.25	6.51	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.27	14.23	0.66	4.96	0.33	3.97	2.65	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.11	12.59	2.74	2.19	0.55	2.19	1.09	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	4.34	13.03	3.62	1.45	0.00	4.34	1.09	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.56	14.95	1.78	1.07	1.07	2.85	2.14	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	8.35	1.19	1.19	0.00	2.39	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	7.45	17.88	1.35	3.52	0.81	4.06	1.49	1.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.04	11.58	0.81	1.35	0.00	1.08	1.62	0.27	0.00
immature langerhans cells, donor1	11904-125F5	31.96	7.99	7.02	5.81	4.36	1.45	2.42	1.70	0.73
immature langerhans cells, donor2	11905-125F6	23.76	6.34	5.54	3.17	3.96	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	1.42	3.41	2.08	0.09	0.66	0.95	0.38	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	3.90	1.30	1.30	2.60	0.65	0.65	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	4.81	4.71	11.31	3.20	0.40	0.70	1.10	0.90	0.60
kidney, fetal, pool1	10045-101F9	3.68	8.91	7.78	1.13	0.92	1.13	0.57	0.50	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.91	33.09	2.27	6.82	1.14	6.25	2.41	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.11	7.19	1.66	1.80	1.11	1.38	0.83	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	3.12	6.24	1.47	2.57	1.28	1.65	0.55	0.37	0.00
left atrium, adult, donor1	10079-102A7	1.09	3.27	2.72	1.09	0.54	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	1.52	2.02	3.03	0.00	0.00	1.01	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	4.10	3.83	1.09	1.64	0.55	1.64	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	0.72	0.36	0.72	0.00	0.00	0.36	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	3.26	2.17	1.09	2.17	0.00	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	6.56	3.16	0.49	3.16	0.00	0.49	0.73	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	5.23	2.09	1.05	4.18	0.00	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.74	6.26	1.89	0.71	0.35	1.89	0.94	0.71	0.00
liposarcoma cell line:KMLS-1	10782-110G8	4.53	1.56	2.66	2.03	0.62	0.62	0.31	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	4.87	14.74	1.10	1.58	0.24	1.58	0.73	0.61	0.00
liver, adult, pool1	10018-101C9	10.53	4.38	7.94	5.19	2.43	1.78	0.65	0.97	0.97
liver, fetal, pool1	10086-102B5	9.41	2.82	0.94	0.94	0.94	1.88	0.94	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	1.60	1.90	2.04	0.87	0.73	0.87	0.29	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	1.66	2.03	4.06	1.11	0.55	0.92	0.37	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	1.41	1.97	1.13	0.85	0.56	1.13	0.85	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	2.52	1.68	3.79	1.26	0.42	0.00	0.84	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	2.49	8.86	2.63	1.94	0.97	2.08	0.28	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	8.27	13.79	0.69	3.45	2.07	2.07	3.45	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2.90	15.95	1.85	0.66	0.79	1.71	1.05	0.66	0.13
lung, adult, pool1	10019-101D1	4.49	5.08	6.97	3.78	1.18	0.47	0.35	0.35	0.47
lung, fetal, donor1	10068-101I5	9.99	7.14	6.56	2.00	1.14	1.71	0.86	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	4.12	1.37	5.96	2.75	1.37	0.00	2.75	1.37	0.46
lymph node, adult, donor1	10077-102A5	3.31	1.89	4.73	1.89	0.47	0.00	4.26	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	5.04	3.95	1.75	2.19	1.32	1.10	0.44	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.28	4.83	4.08	6.94	3.62	0.91	0.75	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	3.40	18.69	5.10	0.85	1.70	2.55	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	2.22	2.66	4.44	1.33	3.55	1.33	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	3.11	3.32	4.77	1.25	2.70	0.83	0.62	0.62	0.42
mature adipocyte, donor3	12233-129G1	4.74	2.13	4.98	0.95	2.37	0.24	0.95	0.00	0.71
mature adipocyte, donor4	12234-129G2	7.37	5.53	7.37	3.16	2.37	0.53	1.32	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1.67	7.86	4.05	0.71	0.95	0.95	0.95	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	2.26	1.13	0.00	1.13	0.00	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	0.74	0.92	3.68	0.37	1.47	0.92	0.55	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	0.95	2.86	0.32	0.64	0.00	0.95	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	2.13	3.84	0.85	1.71	0.43	0.00	0.85	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	0.84	1.86	1.69	1.18	0.68	0.51	0.00	0.17	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	0.64	2.33	4.03	0.42	0.85	0.42	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	3.85	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1.44	2.87	1.44	0.36	1.08	0.72	0.72	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	1.95	3.24	0.00	1.30	1.95	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	2.48	2.63	5.57	1.08	0.77	1.39	0.31	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	1.71	3.18	3.18	0.82	0.57	0.57	0.57	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	1.74	2.43	2.08	0.69	0.69	0.35	0.00	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	4.21	11.07	1.33	0.22	0.22	1.33	0.22	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	2.32	5.75	0.49	0.73	0.61	1.22	0.49	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	2.16	5.89	2.30	1.15	0.43	0.43	0.43	0.14	0.00
melanoma cell line:G-361	10465-106H6	2.99	6.52	1.36	1.36	0.27	0.81	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	7.24	5.97	1.09	2.89	1.99	0.18	1.45	0.90	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.88	0.88	0.00	0.88	0.00	0.88	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1.04	2.33	0.00	0.26	0.26	1.56	0.52	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.52	2.92	1.23	3.22	0.15	0.61	0.61	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.73	3.64	0.91	4.73	0.36	0.36	0.55	0.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.31	2.07	2.48	0.83	0.41	0.00	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.45	1.55	1.40	2.39	0.56	0.56	0.42	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3.85	1.93	1.35	2.31	0.96	0.96	0.00	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.25	0.69	3.47	0.69	1.39	1.39	2.78	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.81	1.37	2.23	1.20	0.34	1.03	0.34	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	3.68	1.38	0.69	1.50	0.46	0.46	0.35	0.58	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.37	3.18	0.93	2.52	0.40	1.06	0.93	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.54	2.70	1.76	2.16	0.68	0.54	0.81	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	6.97	3.13	1.00	2.70	1.14	0.43	0.14	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.92	5.27	2.63	0.99	0.66	1.32	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6.37	3.74	1.11	5.67	0.97	0.69	0.28	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	2.44	1.75	3.84	0.70	0.35	0.35	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.74	2.04	1.02	3.88	0.20	0.82	0.41	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.95	3.24	0.36	0.72	0.36	1.44	0.72	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.38	2.48	0.21	1.24	0.31	0.31	0.93	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.28	1.82	0.46	0.46	0.00	0.46	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.23	2.10	3.78	3.36	0.42	1.26	0.42	2.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.93	3.14	0.90	2.09	0.30	0.45	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.27	2.36	1.14	2.19	0.61	0.44	1.05	0.53	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.58	1.47	0.74	1.10	1.10	0.74	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	3.43	2.29	1.43	1.14	0.00	0.29	0.86	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.63	2.53	1.68	1.26	0.00	0.00	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	2.28	3.65	0.91	2.28	0.00	0.46	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.60	3.07	1.53	1.53	0.26	1.53	1.53	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5.24	3.66	0.79	1.05	0.26	0.52	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	3.70	2.16	0.62	2.16	0.00	0.31	0.31	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5.18	1.41	1.65	0.94	0.47	0.47	0.94	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	2.03	2.37	1.02	1.02	0.68	0.34	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.72	2.36	2.75	3.14	0.79	0.79	1.57	1.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.56	2.32	3.24	1.39	0.00	0.00	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6.63	3.17	2.31	1.73	0.58	0.58	1.44	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.58	3.35	1.12	0.67	0.00	0.67	0.22	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.81	4.09	1.92	1.20	0.00	0.00	1.20	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	1.47	2.20	2.20	1.47	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	3.02	2.01	2.01	0.34	1.34	0.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.91	2.87	2.05	2.05	0.41	0.41	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	4.73	1.29	3.87	0.86	0.43	0.43	0.00	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	2.73	2.73	5.47	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.55	3.90	2.27	1.30	0.32	0.65	0.65	0.32	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	0.00	0.00	0.00	1.45	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	3.20	4.26	0.00	0.00	0.53	1.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	3.27	0.82	0.82	0.00	0.00	0.82	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.05	0.39	0.78	1.17	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	6.30	2.10	0.00	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	0.00	1.99	2.98	1.99	0.99	1.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	9.53	0.00	0.00	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	4.15	1.19	2.96	0.59	0.00	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	2.44	1.22	0.00	0.00	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	1.27	1.27	0.63	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	1.38	3.10	2.07	0.00	0.00	0.00	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	2.15	2.15	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	11.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	0.00	0.00	0.00	3.44	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	3.26	6.11	1.22	0.00	0.41	1.22	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	3.97	6.36	3.18	0.00	0.00	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1.77	1.77	8.25	0.00	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.49	3.12	6.55	0.31	0.00	0.00	0.94	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	1.34	9.36	0.00	2.67	0.00	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	0.00	2.37	0.00	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	5.14	5.14	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	2.75	2.07	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1.48	0.99	0.99	0.00	0.49	0.00	1.48	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	5.61	1.12	0.00	0.00	0.00	0.00	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	2.54	0.00	1.27	0.64	1.27	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1.61	2.42	0.81	0.40	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	1.27	0.00	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.03	1.21	1.21	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	9.04	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	3.29	1.65	0.00	1.65	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.77	1.39	0.99	1.19	0.40	0.00	0.20	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.19	1.30	0.65	1.30	0.65	0.00	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	1.02	1.02	1.02	1.02	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.87	4.64	3.87	0.00	0.77	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	4.72	4.72	5.67	0.71	1.42	1.18	1.65	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	7.18	6.49	0.00	1.62	0.70	0.70	0.46	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.55	11.71	3.19	2.16	0.72	1.64	0.72	0.21	0.31
mesothelioma cell line:Mero-25	10850-111F4	5.45	8.62	2.04	1.59	0.00	0.45	0.23	1.36	0.00
mesothelioma cell line:Mero-41	10851-111F5	2.93	12.71	0.73	1.22	0.24	1.71	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	4.21	4.21	0.00	0.66	0.22	0.22	1.11	0.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	2.37	9.99	1.84	0.26	0.26	0.26	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	3.23	2.21	0.17	1.19	0.34	0.34	0.17	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	7.08	2.02	0.25	1.01	0.25	1.01	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	4.55	1.86	0.62	0.83	0.00	0.41	0.00	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	2.65	3.48	0.50	1.82	0.50	0.33	0.66	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	2.71	4.16	0.18	1.45	0.54	1.45	0.18	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	7.35	4.61	1.02	5.30	0.34	1.02	0.85	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	10.69	6.62	2.80	4.83	1.02	1.53	2.54	0.51	0.25
mesothelioma cell line:No36	10857-111G2	3.26	5.87	0.33	0.98	0.33	0.98	0.98	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	2.44	2.44	0.81	1.08	0.27	0.54	0.54	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	9.79	1.54	9.21	1.73	0.58	0.00	3.07	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	7.57	2.81	6.11	0.73	1.10	0.37	2.32	0.37	0.61
migratory langerhans cells, donor3	11903-125F4	7.90	1.97	9.33	1.44	1.08	0.00	1.44	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.77	10.12	1.96	1.96	1.31	1.63	0.65	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	1.27	1.70	1.06	0.64	0.21	0.85	0.42	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.69	3.23	1.15	1.84	0.69	1.61	1.15	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.23	6.47	6.47	9.13	1.52	0.95	0.38	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.03	2.96	2.59	7.58	1.29	0.74	2.03	1.11	0.37
myeloma cell line:PCM6	10474-106I6	18.58	6.13	4.35	5.14	0.40	1.98	0.79	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.04	6.09	2.54	0.00	0.00	0.51	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.12	3.92	2.55	1.18	1.96	0.20	0.20	1.57	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.68	5.35	4.12	1.78	1.11	1.11	1.00	1.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.80	4.41	4.27	2.06	0.59	0.66	1.69	1.03	0.15
nasal epithelial cells, donor2	12227-129F4	9.38	2.76	2.76	7.73	0.55	1.10	0.55	1.66	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.92	10.12	0.00	0.23	0.00	1.38	0.69	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	1.31	5.99	0.00	0.00	0.19	1.31	0.37	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	6.96	3.80	0.63	0.63	0.42	1.90	0.21	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	3.35	14.35	1.12	0.19	0.00	0.37	1.49	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	3.80	2.37	0.00	0.24	0.24	1.90	0.71	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.06	1.27	0.00	0.79	0.16	0.32	0.48	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	2.01	2.21	0.00	0.00	0.20	1.21	0.40	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.27	2.54	1.27	0.64	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	4.52	4.52	0.27	0.27	0.00	1.06	0.80	0.80	0.00
neutrophil PMN, donor1	12133-128D9	0.00	59.50	29.75	14.87	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	11.84	10.49	1.35	1.35	0.85	1.35	0.85	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	6.40	0.80	0.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.05	4.81	0.64	2.24	0.00	0.96	1.28	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	3.15	3.42	3.42	2.10	0.26	0.79	0.26	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	2.62	3.00	2.06	1.03	0.56	0.84	0.37	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	2.06	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	2.42	2.68	3.49	0.81	0.81	0.00	0.00	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	0.36	2.91	0.00	0.00	0.36	0.00	0.36	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	1.31	1.31	1.57	0.00	0.79	1.31	0.52	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	1.29	3.43	0.00	0.43	0.00	1.72	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	0.24	1.66	1.66	0.00	0.95	0.63	0.39	0.16	0.00
olfactory region, adult	10195-103E6	0.19	1.53	1.72	0.38	0.38	0.38	0.00	0.19	0.00
optic nerve, donor1	10277-104E7	0.00	6.00	2.00	0.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	8.66	11.05	1.82	3.19	1.14	0.91	2.05	1.03	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1.10	3.43	0.82	0.55	0.14	0.55	0.55	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.47	6.60	2.54	4.74	0.34	0.51	1.52	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	1.85	8.43	0.46	1.73	0.46	0.58	0.23	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	3.23	6.47	1.18	0.59	0.88	0.88	0.59	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	5.61	19.62	2.80	2.80	1.87	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	9.75	13.57	4.88	1.27	0.85	0.64	2.54	2.97	0.21
ovary, adult, pool1	10020-101D2	4.02	4.63	3.84	2.36	0.79	0.96	0.70	0.87	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	3.67	8.07	2.20	0.92	0.73	1.65	0.73	0.00	0.00
pancreas, adult, donor1	10049-101G4	0.94	0.94	3.76	0.00	0.00	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.64	6.15	17.61	2.80	2.24	1.68	4.47	3.07	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	9.20	8.01	0.34	3.41	0.68	0.68	0.68	0.85	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	8.28	15.90	2.81	5.63	1.66	2.98	1.32	1.16	0.00
paracentral gyrus, adult, pool1	10035-101E8	1.28	2.65	2.20	0.73	0.37	0.37	0.37	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	1.47	0.00	1.47	0.00	0.73	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	2.82	1.88	4.70	0.00	0.00	0.94	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	2.00	2.00	1.71	0.86	0.86	0.86	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	1.15	2.38	1.85	0.26	0.88	1.06	0.26	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	0.00	1.94	0.97	0.00	0.00	1.94	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	0.75	2.24	0.00	0.00	0.75	0.00	0.37	0.00	0.00
parotid gland, adult	10199-103F1	2.47	0.62	4.32	1.23	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	2.69	0.54	9.13	1.07	0.00	0.00	1.61	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.42	1.12	0.93	0.56	0.37	0.37	0.74	0.19	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	4.37	12.24	0.73	1.75	0.87	1.75	0.58	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	1.94	1.29	1.94	1.94	0.65	2.58	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	5.33	3.55	4.15	3.55	1.18	1.18	0.59	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	0.63	0.63	0.63	1.25	0.00	0.00	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	3.04	1.01	2.02	4.05	0.00	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	6.25	2.08	2.08	3.65	1.04	1.04	2.61	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	0.85	2.55	0.85	1.70	0.85	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	14.73	5.70	5.91	2.37	2.37	0.54	1.72	3.44	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	7.02	7.02	3.31	1.59	0.53	0.79	0.40	0.13	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	5.76	4.36	3.74	3.74	0.93	0.78	0.78	0.78	0.00
pons, adult, pool1	10033-101E6	1.72	1.38	1.64	0.26	1.03	0.95	0.34	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	0.70	2.18	1.74	0.00	0.52	0.52	0.44	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	25.10	2.09	2.09	10.46	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	4.37	3.35	1.46	2.18	0.58	0.87	0.87	1.17	0.15
prostate cancer cell line:PC-3	10439-106E7	6.53	8.89	2.72	2.18	1.09	3.63	1.09	0.36	0.18
prostate, adult, pool1	10022-101D4	4.35	2.81	3.99	1.00	0.73	0.63	0.54	0.18	0.63
putamen, adult, donor10196	10176-103C5	2.36	1.65	1.18	2.12	0.94	0.71	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	3.92	1.96	7.84	3.92	0.00	0.00	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	10.93	1.09	0.00	1.09	1.09	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	0.97	1.93	0.72	0.72	0.24	0.72	0.97	0.00	0.24
putamen, newborn, donor10223	10365-105F5	3.75	1.50	1.50	0.75	0.00	0.75	1.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	11.35	12.51	2.33	6.98	2.62	2.33	0.58	1.16	0.00
rectum, fetal, donor1	10067-101I4	1.39	4.17	0.00	4.17	1.39	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.45	5.30	1.06	1.06	1.06	0.42	0.42	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.49	5.38	2.90	0.83	0.00	1.66	2.07	0.83	0.00
retina, adult, pool1	10030-101E3	3.38	3.58	6.16	1.69	0.50	0.70	0.80	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	2.86	7.53	1.56	0.78	0.26	2.08	0.78	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	3.93	3.81	0.25	1.60	0.86	0.74	0.86	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.25	55.96	5.62	3.37	0.28	12.65	3.37	2.25	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	3.03	8.34	0.00	0.76	0.76	2.27	0.00	0.00	1.52
salivary acinar cells, donor1	11771-123I7	8.58	4.86	1.13	3.24	0.49	0.49	0.81	0.16	0.49
salivary acinar cells, donor2	11772-123I8	7.44	2.89	3.30	2.62	0.55	0.55	0.96	0.69	0.28
salivary acinar cells, donor3	11773-123I9	5.30	7.28	4.63	2.65	0.66	0.00	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	2.29	2.29	4.58	2.29	0.57	1.14	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.94	3.12	0.34	3.54	0.76	1.01	0.59	0.76	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.35	2.70	0.82	3.17	0.59	1.29	0.59	0.94	0.00
seminal vesicle, adult	10201-103F3	4.23	4.76	3.17	5.29	0.00	1.59	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	3.64	6.80	1.21	2.67	1.46	0.97	0.97	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3.52	5.54	0.75	0.75	0.75	0.50	0.25	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	12.04	6.02	1.00	0.00	0.00	1.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1.07	3.63	0.27	0.00	0.27	1.48	1.21	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	2.54	4.75	1.11	0.66	0.88	0.55	0.44	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	12.90	3.87	2.45	6.45	1.29	0.77	2.71	0.90	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	2.13	8.51	0.00	0.00	0.00	0.71	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	1.20	2.64	15.71	0.48	2.28	0.48	0.36	0.24	0.60
skeletal muscle, fetal, donor1	10066-101I3	9.05	3.02	5.03	0.00	0.00	0.00	2.01	2.01	1.01
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	6.94	5.05	5.05	3.79	0.00	0.63	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.33	3.34	0.00	0.33	0.33	0.33	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1.89	13.24	0.95	0.95	0.00	1.26	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	1.93	0.96	0.58	0.96	0.58	2.70	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	2.80	6.59	0.99	0.49	0.00	1.15	1.32	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2.09	16.89	0.00	0.16	1.61	1.61	0.32	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	1.96	10.24	0.44	1.09	0.65	0.87	1.09	0.65	0.00
small intestine, adult, pool1	10024-101D6	6.21	2.27	7.29	2.75	2.87	0.96	2.39	0.00	0.36
small intestine, fetal, donor1	10064-101I1	9.09	1.97	1.47	2.46	0.74	0.49	1.72	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	2.56	4.62	0.51	0.51	0.51	0.00	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	4.14	1.55	5.94	1.29	0.52	0.78	1.29	0.26	1.29
somatostatinoma cell line:QGP-1	10781-110G7	1.07	3.48	0.80	1.88	0.54	0.80	1.61	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	3.90	2.75	3.90	1.84	1.15	0.69	0.23	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	3.55	3.15	8.67	0.39	0.39	1.18	0.79	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	2.08	2.08	2.08	0.00	0.69	0.69	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	4.27	5.49	3.66	1.83	1.83	1.83	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	5.05	1.84	0.92	0.46	0.46	0.46	1.38	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	4.03	6.42	2.24	1.05	0.90	1.79	0.60	0.30	0.00
spleen, adult, pool1	10025-101D7	9.80	5.40	6.50	4.30	2.31	0.99	0.33	0.66	0.11
spleen, fetal, pool1	10044-101F8	6.99	5.48	4.69	2.38	1.51	1.91	0.87	0.24	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.00	3.31	1.45	3.11	0.31	0.72	1.35	0.52	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	6.46	4.94	0.76	1.71	0.95	1.71	1.90	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	2.80	3.84	4.54	1.75	0.35	0.35	1.40	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	12.12	3.52	2.35	2.35	1.17	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1.91	2.70	2.36	1.35	0.79	0.45	0.56	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.78	7.20	1.27	2.12	0.00	1.27	2.54	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	6.77	9.31	1.69	1.69	0.42	2.12	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	5.34	7.48	2.14	3.20	1.07	0.00	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	1.14	2.28	0.57	2.28	1.71	0.00	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	2.70	3.12	6.02	0.83	0.62	1.04	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	0.52	1.55	2.07	0.00	0.00	1.55	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	2.83	0.71	0.71	0.71	0.00	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.40	7.80	1.83	4.59	2.06	1.60	5.50	2.29	0.23
temporal lobe, adult, pool1	10031-101E4	0.68	2.03	1.36	0.25	0.51	1.27	0.17	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1.42	3.56	0.00	0.00	1.42	2.14	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1.76	7.47	0.00	0.44	0.00	2.64	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	7.33	3.84	1.05	2.79	0.70	0.70	1.05	0.35	0.35
tenocyte, donor2	11765-123I1	5.72	3.05	1.91	0.76	0.38	0.00	1.14	1.14	0.38
tenocyte, donor3	11768-123I4	4.45	1.85	1.48	1.11	0.37	0.00	0.74	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.72	28.21	22.60	8.50	0.00	3.06	6.80	7.48	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	4.62	17.11	1.85	1.54	0.00	2.00	0.77	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	15.03	11.31	1.70	2.17	0.46	2.63	2.32	1.55	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.68	16.00	0.89	2.03	0.38	3.30	3.30	2.03	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.53	28.74	9.45	0.76	0.00	1.89	7.19	4.92	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.47	11.78	0.65	1.53	1.31	0.76	3.93	1.74	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.61	21.50	3.26	2.61	1.30	2.61	3.58	3.91	0.00
testis, adult, pool1	10026-101D8	10.31	5.48	6.33	5.48	1.72	1.40	1.07	1.93	0.43
testis, adult, pool2	10096-102C6	4.06	3.61	3.61	2.26	1.35	0.45	1.35	1.35	0.00
thalamus - adult, donor10196	10168-103B6	0.00	2.21	1.10	1.10	0.00	0.00	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	1.88	2.50	4.69	0.63	0.94	0.94	0.31	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	4.62	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	0.49	0.66	1.98	0.16	0.82	0.00	0.33	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	4.03	0.58	1.73	0.00	0.58	0.00	0.00	1.73	0.00
throat, adult	10209-103G2	3.75	2.25	7.49	0.75	1.75	0.00	0.75	0.75	0.25
throat, fetal, donor1	10061-101H7	5.18	4.27	3.35	2.74	0.61	1.22	1.22	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	2.19	5.76	0.00	0.60	0.40	2.19	0.60	0.20	0.00
thymus, adult, pool1	10027-101D9	7.75	6.26	1.69	6.86	3.18	3.28	1.29	0.60	0.10
thymus, fetal, pool1	10043-101F7	7.07	6.86	4.78	5.20	2.08	4.05	1.35	0.52	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	7.05	10.64	3.19	1.20	1.33	2.13	1.86	1.06	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	4.47	7.96	2.24	0.98	0.98	1.54	0.70	0.28	0.14
thyroid, adult, pool1	10028-101E1	2.33	3.45	5.69	1.59	0.93	1.40	0.37	0.37	0.47
thyroid, fetal, donor1	10060-101H6	3.69	2.90	4.48	0.79	0.26	1.05	0.79	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	0.00	9.24	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	5.12	0.93	4.65	0.93	1.16	0.47	1.63	0.47	0.70
tongue, fetal, donor1	10059-101H5	5.52	3.55	10.25	2.36	0.00	0.79	1.18	0.39	0.39
tonsil, adult, pool1	10047-101G2	9.42	5.01	5.91	3.61	1.50	0.60	1.40	0.40	0.80
trachea, adult, pool1	10029-101E2	4.91	4.09	4.01	1.80	1.64	0.74	1.06	0.16	0.16
trachea, fetal, donor1	10058-101H4	7.31	3.46	1.15	1.54	0.77	1.15	0.77	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	5.31	3.90	2.48	1.77	0.35	1.42	0.71	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	4.46	8.31	0.71	1.11	0.91	2.03	0.41	0.41	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.64	3.92	0.94	2.51	0.00	0.78	0.94	0.78	0.00
tridermal teratoma cell line:HGRT	10694-109G1	1.90	11.42	0.00	1.90	1.90	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.81	7.62	0.42	0.68	0.17	1.10	0.93	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	4.17	2.09	4.17	0.00	0.00	0.00	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	33.44	15.36	75.76	9.38	0.68	0.51	2.22	6.65	9.90
uterus, fetal, donor1	10055-101H1	10.24	8.19	4.10	5.12	0.51	1.02	5.63	10.24	0.00
vagina, adult	10204-103F6	3.88	0.00	1.29	0.00	0.00	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	5.92	1.75	2.63	3.07	0.00	0.88	0.00	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.21	2.40	2.94	4.27	1.34	0.80	0.53	0.27	0.27